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Nutrition support is essential to improve health outcomes among HIV-exposed children. 
However, there are few evidence-based models for effective integration of nutrition support 
within clinical Prevention-of-Mother-to-Child-Transmission (PMTCT) services.  To address this 
gap, we aimed: 1) to describe the problem of growth faltering among HIV-exposed uninfected 
infants at GHESKIO clinic in Port-au-Prince, Haiti, 2) to design an age- and context-appropriate 
infant feeding support intervention for this population and 3) to evaluate the effectiveness of 
the intervention in improving growth outcomes.    
Medical record data from 360 HIV-exposed uninfected children seen at GHESKIO between July 
2007 and October 2009 were used to describe the growth pattern from birth to 23 mo (Aim 1). 
They were compared to the WHO 2006 Growth Standard and a nationally-representative 
sample of same-age Haitian children (n=1190).  GHESKIO children were born proportionally 
stunted and improved in weight-for-age and length-for-age across the first 6 mo of life.  
Faltering in weight and length began at 7 mo.  Length faltering continued until 24 mo. 
Outcomes in GHESKIO children were significantly better than the nationally-representative 
sample at age 24 mo.   
As part of the intervention-design process (Aim 2), we identified contextual factors that 
influenced intervention implementation.  The support of higher-level stakeholders was a key 
  
facilitator.  Factors related to the chaotic environment of urban poor HIV-infected mothers 
were the primary barriers.  The caregivers club model provides a promising foundation for 
integration of nutrition support and PMTCT services at GHESKIO. 
To assess the impact of the intervention on growth outcomes among a cohort of 6-12 month 
old HIV-exposed, uninfected children (Aim 3), outcomes in intervention participations (n=72) 
were compared to a historical control group of children in the GHESKIO PMTCT program in the 
previous year (n= 294).  Participation in the 24-week intervention was associated with a 67.3% 
decrease in underweight (p=.007) and 54.7% decrease in stunting (p=.029) around age 12 mo. 
The magnitude of the benefit on prevalence of growth faltering was large compared to other 
infant feeding interventions. Further implementation research is needed to make the 
intervention sustainable in the GHESKIO context and to apply the model to similar contexts 
outside GHESKIO. 
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CHAPTER 1 
BACKGROUND 
 
This dissertation describes the design, implementation and evaluation of an intervention to 
improve growth outcomes among HIV-exposed Haitian children in late infancy.  The research 
was conducted between June 2007 and January 2010 at the Groupe Haïtien d’ E´tudes du 
Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) Centers, an HIV/AIDS and 
infectious disease clinic in Port-au-Prince, Haiti.   
This research stands at the intersection of two high priority and rapidly advancing fields of 
public health practice: improving infant and young child feeding (IYCF) to prevent child 
undernutrition and the prevention of mother-to-child transmission (PMTCT) of HIV in resource-
poor contexts.  The research is timely given a) the magnitude of the global HIV/AIDS epidemic 
and the global burden of childhood undernutrition, b) emerging evidence from ongoing 
research in PMTCT and early childhood undernutrition showing the longer-term implications of 
not intervening in affected populations, and c) the current availability of resources to address 
these problems.  Both PTMCT and childhood undernutrition are priority issues on the global 
health policy agenda.  
Chapter 1 provides an overview of relevant literature on IYCF in the context of HIV/AIDS, the 
Haitian context, and policy-oriented evaluation research.  Overall research objectives of the 
dissertation and specific research questions are identified at the end of this chapter.   
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INFANT AND YOUNG CHILD FEEDING IN THE CONTEXT OF HIV/AIDS 
In this section I will present relevant on IYCF and then PMTCT, concluding with their 
intersection in HIV and infant feeding. 
Infant and Young Child Feeding  
Undernutrition is the underlying cause of 35% of young child deaths globally [2].  In addition, 
protein-energy and micronutrient deficiencies in early childhood can have significant long term 
negative effects on growth, immune function, neurobehavioral development and risk of chronic 
disease [2-4].  Malnutrition potentiates the progression of infectious disease [5, 6] . 
Assessment of child growth  
Growth is the primary outcome and indicator of nutritional status used in this research.  
Growth is a composite indicator of the health status of a young child.  It reflects the combined 
effects of past and present nutritional status as well as disease, injuries, and other non-
nutritional factors. Weight and length1 are relatively simple measures to obtain at the clinic or 
community level and the preferred measures for monitoring and evaluation of child health 
interventions in less developed countries [7, 8]. 
Weight-for-age, length-for-age and weight-for-length are the three most commonly used 
anthropometric indices for nutritional assessment in young children.  Calculation of these 
indices depends on the growth curve of a reference population.  They are most clearly 
                                                 
1
 Length is a recumbent measure of linear growth used for children under 2 years old. Height is a 
standing measure of linear growth used in children age 2 and older.  Children under 2 are the focus of 
this research and therefore the term “length” will be used exclusively to refer to the measure of linear 
growth.    
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expressed as z-scores reflecting the number of standard deviations above or below the 
reference mean or median.  Undernutrition is categorized as underweight (WAZ<-2 SD), 
stunting (LAZ<-2 SD) and wasting (WLZ<-2 SD).   Growth z-scores between -2 to -3 SD are 
classified as moderate undernutrition and z-scores less than -3 SD are considered severe 
undernutrition [8].    
The three indicators (WAZ, LAZ, WLZ) share common determinants but they each reflect “ a 
different combination of biological processes” [8] related to growth.  For all three indices, 
overall risk of death increases with declining z-score and is significantly elevated below –3 SD 
[2].   
Length-for-age is a measure of linear growth that reflects the cumulative effects of malnutrition 
and poor health over a longer period [8].  Early childhood stunting is associated with long-term 
consequences, including reduced adult height, poor intellectual development, lower adult 
economic productivity and lower birth weight in offspring [9].  While very young children can 
recover from stunting through catch-up growth, stunting is not typically reversible after 24-36 
months of age [10]. Length-for-age is an important outcome for interventions looking to 
prevent the long-term effects of undernutrition and is included as a primary outcome in our 
research.    
Weight-for-length is a measure of thinness that is independent of child age.  Changes in WLZ 
can reflect acute changes in weight relative to length.   Severe wasting is commonly termed 
severe acute malnutrition (SAM) and is associated with 5-20 times higher risk of mortality 
compared to well-nourished children [11].  Given their different etiologies, stunting and severe 
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wasting may not be found in the same children.  In analysis of growth data from 19 
Demographic and Health Surveys (DHS) in poor countries, severe wasting was not accompanied 
by stunting in 80-100% of younger children surveyed [2].   Therefore interventions targeting 
populations at risk of one outcome may or may not affect the other.   
Weight-for-age is a composite marker of nutritional status that can reflect acute or longer term 
undernutrition. It is commonly used as an indicator of global undernutrition at the population 
level and is not a specific indicator of the cause of undernutrition in an individual child [8].   
In April 2006 the World Health Organization (WHO) released new Child Growth Standards for 
assessment of growth and development outcomes in children age 0 to 5 years [12].  The new 
standards are based on data from the six-country WHO Multicentre Growth Reference Study 
that followed children from higher socioeconomic status households who were fed according to 
WHO breastfeeding recommendations longitudinally across the first 2 years of life.  Using the 
WHO 2006 Growth Standard, a consistently well-nourished child will track steadily near the “0” 
z-score level across early childhood.   
Introduction of the new standard has important implications for population-level assessment of 
malnutrition and targeting of public health interventions [13].  In particular, the proportion of 
children identified with severe wasting is 1.5- 8 times higher using the WHO 2006 Standard 
compared to the previously used National Center for Health Statistics/WHO international 
growth reference [14, 15].      
Overall patterns of growth faltering based on the WHO 2006 Standards are consistent across 
low-income countries [16].  Mean WAZ and LAZ decline steadily from near birth across the first 
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two years of life.  LAZ levels out around -2 SD after 24 months of age.  WLZ declines from 2-9 
months but improves and levels out near the mean by 24 months of age [16]. These patterns 
suggest that children under age two are the most vulnerable to growth faltering and the most 
likely to benefit from intervention [10, 17-19].  Therefore children in this age group are the 
focus of this research.   
Determinants of child growth 
Growth across early childhood is determined by a number of factors beginning in the prenatal 
period.  The UNICEF framework of childhood malnutrition [20] describes the underlying and 
immediate causes of childhood malnutrition as being related to access to “food, health and 
care” which in turn contribute to adequate dietary intake and risk of infectious  disease.  
Several of the key determinants of growth relevant to the dissertation research are discussed in 
greater detail here.   
Size at birth: Size at birth is associated with postnatal growth outcomes. Low birth weight (LBW) 
(birth weight less than 2500 g) is associated with increased risk of early mortality [2].  The 
determinants of postnatal growth patterns among LBW infants are not well understood [21, 
22]. It is important to distinguish infants who are born small because they are preterm (born at 
<37 weeks gestation) and full term infants who are small for gestational age (SGA) due to in 
utero growth restriction (IUGR).  It is possible that an infant is both preterm and IUGR.   
Preterm infants generally demonstrate early postnatal growth failure followed by catch-up 
growth over a 2-3 year period.  Most do not reach the size of their full-term peers [21].  Among 
IUGR infants, infants who are born disproportionally growth restricted (low ponderal index 
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(kg/m3) or “skinny”) demonstrate early catch-up growth while proportionally growth restricted 
infants with normal ponderal index generally do not [23, 24]. Very little data are available about 
the postnatal growth patterns of infants classified as preterm versus IUGR in low income 
countries. LBW infants in Malawi did not reach the same size as their normal weight peers at 12 
months of age [25].  Although the etiologies of preterm and IUGR remain poorly understood, 
the presence of either is a sign of an in utero environment that is not favorable to healthy fetal 
development. 
Dietary intake:  A child’s diet must provide adequate quantities of macro- and micronutrients to 
support healthy growth and development.  Infants and young children have high nutrient needs 
relative to their body size but limited gastric capacity [26].  To achieve adequate intakes, WHO 
guidelines recommend exclusive breastfeeding (EBF) for the first 6 months of life followed by 
the gradual introduction of adequate quantities of energy-dense complementary foods with 
continued breastfeeding until at least  age 2 years [27].  Increased frequency of feeding and 
diversity of food groups in the complementary diet are associated with improved nutrient 
intakes [26].  Fortified foods or micronutrient supplements are recommended for populations 
with low intakes of animal source foods [28].   Caregivers may not have knowledge of 
appropriate foods for children and/or household food insecurity and other structural barriers 
can limit caregiver access to appropriate foods for IYCF and in turn impact growth [29, 30].   
Infection: Infection acts synergistically with undernutrition in a vicious cycle that contributes to 
poor growth. Infections contribute to undernutrition through decreased nutrient absorption, 
anorexia and other metabolic effects.  Undernutrition in turn can lower immune function and 
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increase susceptibility to infection [31].   A higher incidence and duration of diarrheal episodes 
in infancy is associated with increased risk of stunting at 24 months [2].  In a  pooled analysis of 
longitudinal data from 9 low income countries, 25% of all stunting at age 24 months was 
attributed to having  5 or more diarrheal episodes before age 24 months [32].  Other sources 
estimate the contribution of diarrheal illness to risk of stunting to be much lower [2]. 
Environmental enteropathy is emerging as potentially important determinant of growth 
faltering in early childhood.  There is substantial evidence that sub-clinical enteric infections 
contribute to atrophy of the intestinal villi and inflammation which cause increased intestinal 
impermeability, reduced nutrient absorption and diversion of nutrients to activation of a 
immune response [33, 34]. In both the clinical diarrhea and environmental enteropathy 
pathways, improved sanitation and hygiene are needed to reduce risk of exposure to fecal 
bacteria and other environmental pathogens. 
Care: Dietary intake and disease outcomes are influenced by caregiver behaviors [20]. The 
Guiding Principles for Complementary Feeding the Breastfed Child [35] and The Guiding 
Principles for Feeding Non-breastfed Children 6 to 24 months of age [28] describe ideal 
caregiver practices based on current knowledge related to IYCF.  For non-breastfed children the 
principles include 1) providing appropriate amount of food to meet nutrient demands, 2) 
providing food with a developmentally-appropriate consistency, 3) providing meals at 
appropriate intervals based on overall energy density of available foods, 4) ensuring adequate 
micronutrient content of foods, 5) use of vitamin-mineral supplements or fortified products in 
diets lacking animal source foods, 6) meeting fluid intake needs without breast milk, 7) safe 
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preparation and storage of foods to prevent food-borne illness, 8) practicing responsive feeding 
to encourage adequate intake by children, and 9) feeding during and after illness [28].   
Interventions to Improve Child Growth 
The 2008 Lancet Series on Maternal and Child Undernutrition identified a number of effective 
interventions for improving health and nutrition outcomes in young children. In food insecure 
environments, provision of behavior change education around IYCF with a food supplement 
was recommended to reduce risk of stunting and the burden of disease in children 6-24 months 
of age [19].   
Preventive approaches are more effective than recuperative approaches.  A study in rural Haiti 
showed that providing food rations and IYCF counseling to mothers of all children ages 6-24 
months in the target population was more effective in reducing prevalence of stunting, 
underweight and wasting compared to targeting the intervention only to underweight children 
under age 5 [36].    
The magnitude of effect that can be expected from preventative IYCF interventions is highly 
variable.  Caulfield et al. [37] reviewed complementary feeding interventions from the 1970’s to 
1997.  In 5 efficacy trials from breastfeeding populations with low HIV prevalence, improving 
the intake of complementary foods in 6 to 12 month-old infants by 65-302 kcal per day resulted 
in measurable improvements in growth by 0.04-0.46 SD [37]. When the outcomes of 16 
community programs in 14 developing countries were included, achieved improvements in 
child growth translated into reductions in prevalence of malnutrition (<-2 SD) at 12 months by 
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1-19% and malnutrition-related deaths by 2-13% depending on the baseline prevalence of 
malnutrition [37].   
Dewey and Adu-Afarwuah [38] reviewed 42 complementary feeding interventions published 
between 1998 and 2007, subsequent to the Caulfield et al. review.  They classified intervention 
approaches as using education only, food supplementation with or without education, food 
fortification, and other techniques to increase energy density.  The authors concluded that 
overall the interventions had a “modest” effect on growth outcomes with “no single universal 
best package of components” given the need for interventions to reflect local contexts.  Eight 
studies included in the review involved food supplementation with education.  Mean effect 
sizes for these studies were 0.35 (0.18, 0.66) WAZ and 0.17 (0,0.32) LAZ [38].    
The impact of interventions to improve IYCF depends on the baseline health and nutritional 
status of the target population, age of initiation and duration of intervention [26, 37-39]. High 
quality intervention design and delivery increase the potential impact [38].  
In addition to increasing the energy density and micronutrient quality of the infant’s diet, 
effective complementary feeding interventions promote positive maternal feeding practices 
(e.g. frequent feedings, responsive feeding, feeding during illness), food safety (e.g. clean 
water, proper food storage) and hygiene [26, 37, 40].   
Lipid-based nutrient supplements  
This research includes use of a lipid-based nutrient supplement (LNS).  LNS are energy-dense 
pastes typically composed of peanuts or other legumes, dry milk powder, sugar, oil and 
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micronutrient premix.  They are shelf stable products with low risk of contamination and no 
cooking requirements.   Peanut-based LNS have been locally produced to international quality 
standards in Haiti, Malawi and other under-resourced contexts [41].  
LNS were first used in public health practice in the early 2000’s. LNS formulations known as 
ready-to-use therapeutic foods (RUTF) are promoted for the rehabilitation of children with SAM 
in a community setting [42, 43]. Clinical and community trials of RUTF products in Senegal and 
Malawi [44] have demonstrated successful rehabilitation of malnourished children including 
HIV-infected children, at rates equal or faster to standard inpatient rehabilitation programs 
using specially formulated therapeutic milks (F-75/100) or corn-soy blend [44]. Community-
based Management of Acute Malnutrition using RUTF is now the global recommendation for 
treatment of SAM [11]. 
There has been growing interest in the use of LNS for prevention of malnutrition.  A range of 
strategies are being tried including using small amounts of LNS as a vehicle to deliver 
micronutrients [45], use of LNS as a fortified complementary food for children 6-24 months of 
age [46-49] and large-scale blanket distribution of supplementary LNS rations to populations at 
acute risk of food insecurity [50-52]. Despite their popularity, studies thus far have 
demonstrated only a small relative improvement in growth outcomes when LNS-based 
preventative approaches are compared to the existing standards of care including multivitamins 
or micronutrient powders for micronutrient supplementation [45] and cereal-based fortified 
complementary foods [53]. 
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There are potential advantages to using LNS compared to non-lipid based food supplements in 
populations with low intake of dietary fats [54].  Diets of children in low-income countries are 
often deficient in n-3 fatty acids [55].  Preliminary evidence suggests that improved intakes of 
polyunsaturated fatty acids in deficient populations are associated with improved growth, 
immune and development outcomes [56].   However consumption of  LNS produced solely with 
seed plant-oil sources that are very low in linolenic acid could exacerbate the suboptimal 
balance of n-6 versus n-3 fatty acids and cause visual, cognitive or behavioral deficits [57]. LNS 
that use dried milk powder are very costly to produce but may be more effective than versions 
that use soy or other plant-based protein sources [58, 59].   
 Since 2009 there has been large-scale donor investment in research around LNS use and 
production [60].  An ongoing debate around international patent protection of the basic LNS 
formulation has affected the roll out of local LNS production in some countries [61]. Local 
production is seen as way to promote economic development by supporting the national 
agricultural sector and local food industry.  It also has potential to reduce financial and logistical 
barriers  associated with foreign imports such as tariffs and transport delays.  
IYCF policy environment   
The 2008 Lancet Series estimates that implementation of existing nutrition interventions of 
known effectiveness could reduce burden of early childhood stunting by one-third and 
mortality by one-quarter [19].  Over the last 5 years there has been a coordinated call to action 
[62] and response by policy makers in UN agencies, the World Bank [63], country governments 
[64] and major donors [65, 66] towards prioritizing interventions and policies that target 
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improved nutrition outcomes.  The prenatal period through the first 2 years of life, sometimes 
referred to as “the first thousand days of life or “the window of opportunity,” is the priority 
period for intervention. While the role of agriculture and food production is increasingly 
recognized, models for the effective integration of nutrition-focused activities into existing 
health and agriculture sector initiatives are not yet well developed or documented [63, 67].  
This research aims to build upon current knowledge related to effective IYCF interventions to 
help fill this gap.   
Prevention of Mother-to-Child Transmission of HIV  
Each year, an estimated 1.4 million HIV-infected pregnant women living in low and middle 
income countries give birth [68-72].  An HIV-infected mother can transmit the virus to her child 
in utero, at the time of delivery or in through breast milk.  Since 1999, advances in PMTCT 
programs have reduced mother-to-child HIV transmission rates in less-developed countries 
from 15-35% without intervention [73] to 2-5% with an intervention package that includes 
treatment with highly active antiretroviral therapy (HAART) for pregnant women with advanced 
HIV disease, short-course antiretroviral (ARV) prophylaxis for less advanced maternal cases, and 
support for safer infant feeding [74-76].     
However, global coverage of PMTCT interventions remains inadequate. The universal coverage 
goal is 80% of HIV-infected pregnant women having access to PMTCT drug prophylaxis [77].  In 
2009, just over half (53%) of HIV-infected pregnant women living in low and middle income 
countries received any form of ARV [78].   
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With or without intervention, the vast majority of the children born to HIV-infected mothers 
will not become HIV-infected through vertical transmission [73], however all children of HIV-
infected mothers face substantial risks to their growth, development and survival [79].  
All HIV-exposed children are born small compared to unexposed peers [80].  HIV is associated 
with elevated risk of preterm birth and LBW [81]. Exposure to certain HAART regimens in utero 
has been associated with even higher rates of LBW, IUGR and/or preterm delivery [82, 83]. The 
mechanisms by which exposure to HIV in utero with or without ARVs impacts fetal growth are 
not understood.   
HIV-infected children are at high risk of early postnatal growth faltering. They experience higher 
rates of stunting and underweight compared to HIV-exposed uninfected children in the same 
populations [80, 84].   Pediatric HAART is associated with improved growth outcomes [85, 86].   
The postnatal growth pattern of HIV-exposed uninfected children from less-developed 
countries has not been well characterized [80].  Most published studies of growth outcomes in 
this group were conducted before the year 2000 – when PMTCT and HAART for mothers with 
advanced disease were not yet available.     
Perinatally HIV-infected children are at extremely high risk of early death [87].  Advances in the 
availability of Early Infant HIV Diagnosis using PCR methods and pediatric HAART have improved 
survival outcomes in these children in more resourced settings [88].   
 High rates of mortality among HIV-exposed uninfected infants have been seen in African 
contexts. In rural Uganda, cumulative 2-year mortality rates among uninfected infants born to 
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HIV-infected mothers (165.5/1000 live births) without treatment intervention was significantly 
higher than in uninfected infants born to HIV-negative mothers (128.1/1000 live births) [89].   
The causes of increased mortality among HIV-exposed uninfected children can be difficult to 
discern in contexts with high intrinsic rates of infant and child mortality. Poor infant feeding 
practices including suboptimal breastfeeding and replacement feeding are associated with 
increased mortality outside the context of HIV [90, 91]. Poor maternal health, economic 
vulnerability and food insecurity in HIV-affected households may increase child malnutrition 
and decrease access to medical care [92, 93]. High rates of bacterial sepsis (e.g. Stapylococcus 
aureus) [94] and parasite infection (e.g. cryptosporidiosis ) [20] contribute to the growth 
deficiencies and the disease burden.   
WHO protocols from 2000 and 2006 recommended providing all HIV-exposed infants with the 
antibiotic cotrimoxazole from 4-6 weeks of age until the child’s HIV status is confirmed and 
there is no longer risk of HIV transmission through breastfeeding [95].  In HIV-infected children, 
cotrimoxazole prophylaxis is associated with reduced morbidity and mortality primarily related 
to pneumonia [96, 97], and improved growth and anemia outcomes [98].  In HIV-exposed 
uninfected infants, cotrimoxazole prophylaxis reduces colonization with pneumonia-causing 
bacteria [99], and prevents malaria [100] but the benefit on overall morbidity, mortality and 
growth outcomes is not known [98, 101]. Concerns about increased risk of diarrhea [96], drug 
side effects and development of antibiotic resistance in HIV-exposed uninfected children have 
led some people to question the current recommendation for routine prophylaxis of all HIV-
exposed children [101]. 
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Infant feeding and HIV 
Breastfeeding is a cornerstone of strategies to promote child survival, but for infants of HIV-
infected mothers, breastfeeding carries the risk of HIV transmission.   Transmission risk 
depends on a number of factors including breastfeeding frequency, duration and pattern (e.g. 
EBF or mixed feeding), stage of maternal infection, disease progression and use of ARVs in 
mother and/or child [77].   Kourtis et al. [102] estimated that without other intervention, ~6% 
of HIV-exposed children who are uninfected at birth would become infected through EBF until 
age 6 months, eleven percent would become infected  if they were mixed fed for 6 months and 
then weaned at 1 year, and 15% of infants would become infected if breastfeeding continued 
until age 2.   
Global recommendations around breastfeeding by HIV-infected women in less-developed 
countries have changed considerably over the last decade due to expanded access to ARVs and 
emerging evidence about transmission and mortality endpoints associated with different 
feeding patterns [77, 103-106]. The 2006 WHO guidelines [105] were in place during most of 
the dissertation  research period and will be discussed in greater detail.  I will follow with a brief 
review of changes introduced in the more recent WHO 2010 guidelines [103].  
WHO 2006 guidelines for infant feeding by HIV-infected mothers recommended the proper use 
of replacement feeding methods (e.g. infant formula with clean water, other animal milks, 
expressed and heat treated breast milk) when feasible, or EBF from birth with early cessation of 
all breastfeeding as soon as an alternative was available [105, 106]. WHO guidelines stressed 
the need for counseling that helped individual mothers assess whether replacement feedings 
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options were “AFASS” (acceptable, feasible, affordable, sustainable, safe) given her individual 
circumstances. In practice, HIV-infected women choosing to breastfeed were encouraged to 
wean children between 4-6 months of age [107, 108].  Therefore under the standard of care at 
the time, breastfeeding was not likely to continue past 4-6 months of age.   
WHO guidelines for feeding the non-breastfed child between 6 to 24 months of age, stress the 
importance of providing other milks (e.g. animal milks, treated breast milk) or infant formula to 
meet the energy density and fluid intake needs normally provided by breast milk during this 
period (Table 1) [28]. In Haiti, as in many other AIDS-affected contexts, a month’s supply of 
formula costs about US$ 40-70, far beyond the economic means of the population.  In 
populations with limited access to animal source-foods, WHO guidelines recommend feeding 
children micronutrient-fortified products [28]. 
Table 1.1: Average breast milk contribution to total energy intake from 0-23 mo [26] 
Age 
Total daily energy 
requirement   
Breast milk 
contribution  
birth to 5 mo - 100% 
6 to 8 mo 682 kcal 60.5% 
9 to 11 mo 830 kcal 45.7% 
12 to 23 mo 1,092 kcal 31.6% 
 
At the time of this research, babies of HIV-infected mothers in resource-poor contexts were 
frequently forced to make a rapid transition from a milk diet (i.e. EBF or infant formula) to a 
diet without either of those forms of milk. Availability of published data documenting HIV and 
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infant feeding practices after age 6 months is limited.  One such study from the Ivory Coast 
followed a cohort of 262 HIV-exposed infants who were weaned from EBF at 4 months and 
found an association between inadequate complementary feeding practices at 6 months and a 
37% increased risk of stunting at 12 months.  This was in spite of the fact that infant formula 
was provided at no cost between age 4-9 months in the study population [109].  Studies among 
HIV-infected mothers in Malawi [110] and Zimbabwe [110]  who practiced early weaning also 
showed that that the post-weaning replacement diets were grossly inadequate in both energy 
and micronutrients. 
Multiple studies conducted in sub-Saharan Africa that were published between 2008-2010 
demonstrated an increased risk of growth faltering, morbidity and/or mortality among HIV-
exposed replacement-fed children and HIV-exposed children who were weaned before 4-6 
months compared to HIV-exposed children who continued breastfeeding [111-113].  In several 
studies, there was no difference between groups in “HIV-free survival,” a combined endpoint 
that reflects HIV transmissions and/or death [114-116].  HIV infections prevented by 
replacement feeding were fully offset by diarrhea and malnutrition related deaths cause by 
replacement feeding.   
In light of these results and also new evidence about the protective effect of HAART on 
transmission during breastfeeding [76, 117], the WHO 2010 guidelines recommend 
breastfeeding through 12 months of age accompanied by maternal HAART for all women with 
CD4<350 cells/μl.  In cases where the mother does not qualify for HAART, extended ARV 
prophylaxis is recommended for the mother or infant until 1 week post weaning.  The AFASS 
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criteria for replacement feeding are more thoroughly defined under the 2010 guidelines.  
Instead of emphasizing individualized decision making by the HIV-infected mother, the 2010 
guidelines recommend that national-level policy makers decide which infant feeding approach 
will be the primary strategy promoted among HIV-infected women in their context [103].  
Conceptual framework  
To summarize the relationships between infant feeding and child growth in the context of HIV 
described above, Figure 1 identifies the underlying causes of poor postnatal growth in HIV-
exposed infants.  The figure is based on the expanded version of the 1990 UNICEF framework 
published by Engle et al. [20] which makes an explicit distinction between the resources needed 
for caregiving and the actual practice of caregiving (e.g. suggesting that resources are necessary 
but not sufficient for practice).  This distinction is particularly useful in guiding evaluation design 
as indicators of resource availability and use should be considered separately [118, 119].   
The grey box reflects prenatal factors that are hypothesized to impact growth outcomes at 12 
months of age. These include factors that act as an underlying cause. (e.g. access to prenatal 
PMTCT is associated with risk of pediatric HIV infection which in turn directly impacts growth 
between 6-12 months) or that influence growth potential more directly (e.g. through “fetal 
programming”).   
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Figure 1.1 Underlying causes of growth among urban poor HIV-exposed infants  
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THE HAITIAN CONTEXT 
The dissertation research was conducted in Port-au-Prince, Haiti.  Haiti is the poorest country in 
the Latin American and Caribbean region and ranks 145 of 169 countries on the UNDP Human 
Development Index [120]. Eighty percent of the national population lives on less than US $2 per 
day [121]. Fifty-six percent of the urban population lives on less than US $1 per day [122]. In 
urban areas, 71% of the population has access to clean water and 24% to improved sanitation 
facilities [123]. These figures are substantially lower in rural areas.   
Years of poor governance, internal conflict and natural disasters have resulted in economic 
devastation, loss of human capital, depletion of natural resources, and weakened institutions in 
Haiti.  Recent years (2003-present) have been marked by waves of violence and insecurity 
centered in Port-au-Prince’s slum communities. A United Nations peacekeeping force has been 
actively patrolling urban centers and some rural Haitian provinces since 2004.  Compared to 
rural residents, urban residents have higher material living conditions but live in much greater 
fear of crime and violence [122]. Despite security concerns, rural to urban migration continues 
at a rapid rate [122].  
The year 2008 was particularly challenging year, with food riots in April, a change in 
government that left the prime minister position unfilled for six months and four consecutive 
hurricanes in August and September that caused deadly flooding [124]. The year 2009 was 
notable for relative stability.  In January 2010, at the end of the research period, Port-au-Prince 
was devastated by an earthquake of 6.9 magnitude on the richter scale that was estimated to 
have killed 230,000 people and displaced more than 1.7 million people [125]. 
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Food insecurity is high in both urban and rural Haiti. Fifty-eight percent of the population has a 
caloric intake is below the minimum dietary energy requirement [126]. National agricultural 
production is not sufficient to meet national need and households depend on purchase of 
imported products which are subject to global price fluctuations.  The combined index for flour, 
oil and rice prices in Port-au-Prince increased 35% between January 2005 and December 2007, 
vastly exceeding general inflation [127]  
Child health: Haiti has high rates of childhood malnutrition.  Table 1.2 compares national 
underweight (WAZ < -2 SD), stunting (HAZ < -2 SD), and wasting (WHZ < -2 SD), among children 
under 5 in metropolitan Port-au-Prince to rural and national data. The rural-urban gap may be 
partly explained by the greater range in socioeconomic status in urban populations and does 
not necessarily reflect better health among the poorest urban children compared to their rural 
peers [128].   
Table 1.2      Percent of Haitian children under 5 yr old with WAZ HAZ,             
< -2 SD using by region, WHO/NCHS Reference [1] 
Region  n WAZ HAZ WHZ 
National
1
 2904 18.9 29.7 10.3 
Rural (all zones) 1938 21.2 34.6 11.4 
Port-au-Prince Metro 945 12.1 21.7 7.9 
NOTES:
 1 
Using WHO 2006 Growth Standard:  WAZ<-2 SD 19.21%, HAZ<-2 SD 30.13%,                                                                
WHZ <-2 SD 10.34% [129] 
Consistent with global patterns, national data suggests that most stunting occurs between 6 
and 24 months of age after which stunting prevalence levels off (Figure 1.2).  The trend in 
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Figure 1.2 Percent of Haitian children under 5 years with LAZ, WLZ, and                           
WAZ < -2 SD by age group, National Data, WHO/NCHS Reference [1]   
underweight mirrors stunting through early childhood. Wasting is less prevalent and declines 
from the second year of life.   
 
 
Comparison of DHS findings from 2005-2006 [130] to similar surveys in 2000 [131] and 1995 
[132] show that after a 8.9 % fall in stunting between 1995 and 2000, rates of malnutrition 
increased slightly between 2000 and 2005-06. However, the 2005-6 survey was conducted 
during peak years of political violence and insecurity [130]. 
Among children under age 2 years, prevalence of diarrhea reported by caregiver in the previous 
2 weeks was highest in the 6-11 month age group (40.9%) compared to 0-6 (22.2%) and 12-23 
months (37.7%) [130].   
Infant and Young Child Feeding:  Almost all Haitian mothers breastfeed but few do so 
exclusively.  In the 2005-2006 DHS, median duration of any breastfeeding in metropolitan Port-
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au-Prince was 14.5 months compared to 19.2 nationally.  Median duration of EBF was a very 
short 0.5 months in Port-au-Prince and 1.5 months nationally. However, breastfeeding initiation 
rates are high.  Only 2.2.% of  mothers nationally reported not breastfeeding their child during 
the first 2 months of life [130]   
In the 2005-2006 DHS,  23.3% of mothers of infants less than 6 months old reported feeding 
non-liquid foods to their infants [130].   The cereal-based porridges commonly prepared as 
weaning foods in both urban and rural Haiti are generally energy sufficient but lack essential 
micronutrients including vitamin A, iron and zinc [133].  Frequency of feeding episodes is low, 
with many mothers stopping feeding solid and semi-solid foods by the early afternoon  [133].  
Haitian infants in low income households have little to no access to animal-source foods.  Even 
in rural farming communities, milk is a rare commodity and not commonly fed to breastfeeding 
children [133]. Boxed ultra-heat-treated milk, canned evaporated milk and dried milk powder 
are readily available in urban markets, but are expensive.   
HIV/AIDS: In the 1980s and 1990s, Haiti faced the most rapidly growing HIV/AIDS epidemic in 
the Western Hemisphere.  Through a coordinated national response that included early 
recognition of the epidemic by the Haitian medical community [134], efforts by the Haitian 
government and Red Cross to ensure safety of the blood supply [135] and scale-up of 
prevention and treatment services led by two large national Non-Governmental Organizations 
(NGO), HIV prevalence rates among pregnant women in Haiti fell from 9.4 % in 1993 to 3.7 % in 
2003.  In 2007 prevalence in Haiti was 4.4% among pregnant women and 2.2 % among all adults 
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age 15-49 years [136]. As of 2008, the estimated number of persons living with HIV in Haiti was 
115,000 [136].  Two-thirds of HIV-infected individuals live in Port-au-Prince.   
Pediatric care at the GHESKIO Centers 
Founded in 1982, the GHESKIO Centers is a private Haitian institution dedicated to clinical care, 
research and training in HIV/AIDS and related diseases. GHESKIO’s primary site is located in the 
center of Haiti’s capital city, Port-au-Prince, immediately adjacent to the city’s largest slum 
communities.  It draws clients from across the greater Port-au-Prince area.  Free services 
provided to this predominantly urban poor population include HIV voluntary counseling and 
testing (VCT), adult and pediatric HIV care, tuberculosis screening and treatment, sexually 
transmitted disease diagnosis and treatment, and PMTCT of HIV and syphilis. The number of 
people seeking HIV testing at GHESKIO has increased nearly 7-fold from 3,450 to 23,313 over 
the past decade, with 72% of those clients self-referred in 2004.   
GHESKIO provides a unique research-oriented environment where high-quality clinical HIV care 
is delivered to a population affected by generalized poverty and insecurity.  GHESKIO is led by 
an outstanding Haitian physician, Dr. Jean William Pape, and despite health workers shortages 
nationwide, maintains a staff of highly qualified physicians and nurses.  GHESKIO’s HIV care is 
primarily supported by PEPFAR, the Global Fund for AIDS, Tuberculosis and Malaria, the US 
National Institutes for Health  and the Rodolphe Mérieux Foundation.  It has strong academic 
ties with Cornell and Vanderbilt Universities. Treatment outcomes for GHESKIO’s adult patients 
on HAART are comparable to those of patients treated in HIV clinics in the best academic 
medical centers in the United States [137]. 
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Pediatric clinical services:  GHESKIO’s pediatric clinic provides comprehensive care for children 
ages 0-10 years old.  It is staffed by a highly qualified team of three Haitian physicians, two 
nurses and two field workers. Care for HIV-infected pregnant women and adolescents (11-21 
years old) is provided by separate units within GHESKIO.  Three populations of children under 
age 2 are seen by the pediatric unit: a) children born to HIV-infected mothers enrolled in 
GHESKIO’s PMTCT program (referred to here as “PMTCT children”) b) children born to HIV-
infected mothers who did not receive PMTCT services at GHESKIO but may or may not have 
received services elsewhere (referred to here as “non-PMTCT children”) and c) children born to 
HIV-negative mothers.  PMTCT children represent more than 75% of all infants seen at the 
GHESKIO pediatric unit.  Table 1.3 summarizes clinical services provided to each of these 
populations.   
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Table 1.3 GHESKIO Pediatric services by sub-population 
Service Description 
HIV-positive mother 
HIV-Negative 
mother 
PMTCT Non-PMTCT 
Routine physician 
visits* 
0-3 month olds Every 2 wks Every 2 wks Every 2 wks 
4-6 month olds Monthly Monthly Monthly 
7-9 month olds Every 3 mo Monthly Monthly 
12-24 month olds  Every 3 mo N/A N/A 
Sick child visits 
Walk-in visit due to sick child (e.g. 
diarrhea, fever) 
All All All 
HIV testing 
RNA test – confirm status by 4 mo.  
Antibody test – require 2 negative  
tests to confirm sero-evert before  
12-18 mo 
RNA test at  
0 and 4 mo; 
or antibody 
Antibody tests 
every 3 mo  
Antibody at 
enrollment 
Vaccination* 
Ministry of Health  (MOH) series : 
BCG, Polio, DPT, Measles  
Expanded pkg: Hep B, HIB, 
Pneumovax  
MOH+ 
Expanded 
MOH  MOH 
Vitamin A  
High dose of Vit A every 4-6 mo 
starting at age 6mo 
All All All 
Pediatric HAART For infant confirmed positive  All* All* N/A 
No-cost infant formula Free Enfamil offered from 0-6 mo
¥
 All
¥
 
special cases 
only 
None 
Cotrimoxazole 
prophylaxis  
Cotrimoxizole given from birth 
until HIV-negative status 
confirmed 
All All None 
Multivitamin syrup 
Prescription for pick up at GHESKIO 
pharmacy – stock out common All All All 
Fortified cereals 
Limited supply of fortified infant 
cereal in transition period (4-7 mo) 
Select cases 
Special cases 
only 
Rarely 
NOTES: *  ALL infants who are  confirmed to be  HIV-positive are monitored monthly by physicians, 
started on ART  and offered the expanded vaccine package. However, HIV-positive infants under age 2 
are not common at GHESKIO due to availability of PMTCT services.  
¥
 PMTCT infants enrolled in 5207 
study receive formula for 1 year per AIDS Clinical Trial Group Protocol 5207.  N/A = not applicable. 
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Outcomes in GHESKIO PMTCT children:  GHESKIO’s PMTCT program started in 1999 using 
nevirapine monotherapy for perinatal ARV prophylaxis. In 2003, HAART became available for 
HIV-infected mothers with CD4 < 250 cells/μl and all HIV-infected infants. In 2006, GHESKIO and 
the Haitian Ministry of Health and Population revised ARV prophylaxis protocols to require 
consideration for the stage of pregnancy at PMTCT program enrollment and maternal health 
status in determining which combination of drugs (e.g. AZT, nevirapine, 3TC) are given to 
mother and infant and for what duration.  All pregnant women at GHESKIO are counseled about 
infant feeding options and associated risks. Infant formula was provided free from birth to age 
6 months to mothers who chose to replacement feed. After birth, mothers and infants have 
regularly scheduled follow-up visits at the PMTCT clinic and pediatric clinics respectively.   
Mother-to-child HIV transmission and survival outcomes from 0 to 15 months were published 
for a cohort of 551 children born to GHESKIO PTMCT mothers between 1999 and 2005 [75].  
The follow-up period allowed for comparison of outcomes pre-HAART availability versus post-
HAART availability. Twenty percent of infants were LBW.  Eighty-five percent were formula fed 
from birth. Overall MTCT rate across the period was 10.2%; but it was only 1.9% among the 52 
infants whose mothers were on HAART during pregnancy for at least 60 days prior to delivery.    
Overall infant mortality rate was 15.2 per 100 births.  The mortality rate pre-HAART was 0.23 
per child-year followed compared to 0.12 per child-year followed post-HAART (p<0.0001).  In 
multivariate models, LBW and infant HIV-status were predictive of mortality risk [75]. 
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 EVALUATION RESEARCH  
As described above, there is a substantial knowledge and experience gap around the translation 
of PMTCT and IYCF recommendations into feasible interventions that improve infant growth 
outcomes in the context of HIV.  The dissertation research aimed to contribute towards filling 
that gap by conducting a scientifically rigorous evaluation of an intervention designed based on 
current PMTCT and IYCF recommendations.  In order to be useful for public health decision 
making, the evaluation needed to meet the needs of policy and program delivery stakeholders.   
Public health policy makers aim to identify effective intervention models that can be scaled and 
replicated across contexts.  Results from impact evaluations are an important tool used by 
policy makers, program planners and implementers for decision making.  However, evaluations 
often fail to assess how a program achieved its impact including the various contextual and 
delivery-related factors that may have contributed to the program outcomes [138, 139].  As a 
result, we often do not understand why interventions with proven efficacy or effectiveness in 
one context may fail to produce the same impact when they are implemented in a different 
context. 
Delivery contexts for IYCF interventions are often complicated.  Many efficacy-oriented 
evaluation approaches attempt to “control” for contextual factors and minimize bias from 
these factors via randomization. However it is these very factors that influence whether or not 
interventions will be effectively integrated into routine service delivery [139].  Implementation 
research approaches that aim to understand contextual factors and delivery processes have 
been underdeveloped in the field of public health [139] but are increasingly being utilized [140, 
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141].  As a result of constraints in publication formats, published studies involving complex 
interventions often lack the level of detail needed to fully understand intervention inputs, 
delivery process and context [142].   
The dissertation research used an evaluation approach guided by program theory in order to 
answer the “how” and other contextual questions.  A program theory is an explicit model of the 
pathways, including intermediates and mechanisms, that link program inputs to outcomes [118, 
138].  Program theory helps to distinguish different ways inputs might contribute (or fail to 
contribute) to intended outcomes.  Evaluations guided by program theory can help account for 
interventions that do not achieve their intended outcomes due to poor implementation, 
contextual issues or having an incorrect model to start with [118].   
In several regards, the current environment around HIV and infant feeding policy and 
programming provides an ideal context for applying evaluation approaches guided by program 
theory.  Interventions to improve IYCF are very context specific.  PEFPAR, Global Fund and other 
donors are making large-scale investments in delivery of integrated PMTCT and MCHN services 
but lack evidence around effective models at the service delivery level [140, 143]. Several IYCF 
intervention studies outside the context of HIV/AIDS have used program-theory guided 
approaches to understand the implementation-related factors contributing to intervention 
impact [36, 144-148].   While randomization to treatment groups is considered by some in the 
global health policy community to be the gold standard approach for evaluation research, 
randomization to “no treatment” is often not ethical in infant feeding interventions in 
vulnerable populations [149].  A program-theory based analysis can strengthen causality 
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arguments in non-randomized designs and also be incorporated into a randomized controlled 
design in order to better answer the “how” questions that affect adaptation and scale-up to 
other contexts [149].   
OVERALL RESEARCH OBJECTIVE OF THE DISSERTATION   
The overall objective of this research was to design a contextually appropriate Infant Feeding 
Support Strategy (IFSS) for GHESKO infants age 6-12 months and to evaluate whether the IFSS 
was effective in improving growth outcomes.  
Chapter 2 describes the multiple levels of context that influenced the design and 
implementation of the IFSS.  Key lessons learned about integration of programs at the service 
delivery level are identified.   Chapter 3 presents results from an analysis of the pre-
intervention growth status of the GHESKIO population under 24 months of age and provides 
the rationale for intervening in this population during late infancy.  Chapter 4 presents the 
results of the impact evaluation and supporting program-theory-based analysis.  A discussion of 
the overall findings, their implications and recommendations for future research is found in 
Chapter 5.    
The full program theory model for the intervention evaluated in this dissertation is included in 
an appendix.    
Specific research questions for Chapter 2 
1) What is the average growth trajectory from birth to 23 months of age among HIV-exposed 
uninfected children under the GHESKIO standard of care? 
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2) What are the predictors of growth faltering in this population? 
3) How does the growth pattern of GHESKIO children compare to their peers in the general 
Haitian population? 
Specific research questions for Chapter 3 
1) What is the problem that led to the development of a new IFSS at GHESKIO? 
2) What were the contextual factors that influenced the IFSS design?  
3) What were the key lessons learned from the design, implementation and evaluation 
experience that can be applied to development of future integrated PMTCT and maternal 
child health and nutrition delivery strategies?   
Specific research questions for Chapter 4 
1) What was the magnitude of effect on growth associated with participation in the IFSS? 
2) Were growth effects associated with the intervention sustained 6 months post-intervention?  
3) Is it plausible to attribute the observed growth effects to participation in the intervention? 
The answers to these research questions have important implications for addressing the gap in 
knowledge around the effective delivery of integrated PMTCT and children health and nutrition 
interventions.  
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CHAPTER 2 
LESSONS LEARNED FROM THE INTEGRATION OF AN INFANT FEEDING SUPPORT STRATEGY  
INTO A CLINICAL PMTCT PROGRAM IN URBAN HAITI 
 
ABSTRACT 
The President’s Emergency Plan for AIDS Relief program guidance calls for the integration of 
Prevention of Mother to Child Transmission, pediatric HIV care and maternal newborn and child 
health services including nutrition support provided to HIV-affected populations.  There is 
limited information available to guide the development of integrated interventions appropriate 
for local service delivery contexts.  In 2007-2009 the GHESKIO Centers in Port-au-Prince, Haiti 
implemented a new Infant Feeding Support Strategy for HIV-exposed infants age 6-12 months.  
The strategy was developed to address the increased risk in growth faltering observed in 
GHESKIO infants after six months of age – an age group that GHESKIO’s existing infant feeding 
support protocols did not cover. We identified six key contextual elements that facilitated or 
restricted the overall intervention design including institutional support, donor mandate, 
learning from existing program models outside the context of HIV, limited availability of 
appropriate supplements, the chaotic lives of poor urban mothers, and GHESKIO’s existing 
model of care.  Five “lessons learned” that can be applied to development of new integrated 
programs are 1) integration at service delivery level must be driven by the needs of the end 
users,  2) group-based strategies provide a channel for delivery of integrated services with 
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added benefit of social support,  3) delivery of integrated services among chaotic populations 
requires a skilled, motivated and flexible staff team,  4) delivery of integrated programs 
requires compromise by internal and external stakeholders, and 5) integrated programs require 
evaluation designs that can assess the contribution of various components to overall outcome.   
Implications of these lessons for GHESKIO’s expanded intervention model for integrated 
Prevention of Mother to Child Transmission and maternal child health and nutrition care are 
considered.        
INTRODUCTION  
In 2003, the United States Government (USG) launched the President’s Emergency Plan for 
AIDS Relief (PEFPAR) a five-year initiative aimed at rapidly improving access to HIV prevention, 
care and treatment services in low-income countries with high prevalence of HIV/AIDS.   Haiti is 
one of 15 focus countries that received substantial PEPFAR investment. With the renewal of 
PEFPAR in 2008, the initiative has transitioned from an “emergency response” focused on 
rapidly scaling up antiretroviral (ARV) drugs for HIV treatment and Prevention-of-Mother-to-
Child Transmission (PMTCT) programs to helping countries develop more comprehensive 
packages of health services for HIV-affected individuals and their communities [1].  
PEFPAR guidance from January 2011 calls for integration of PMTCT, pediatric HIV care and 
maternal newborn and child health services provided to HIV-affected populations [2].  PEFPAR 
defines integration as “the organization, coordination and management of multiple activities 
and resources to ensure the delivery of more efficient and coherent services in relation to cost, 
output, impact and use (acceptability).”  Models for effective integration of maternal and child 
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health and nutrition (MCHN) services exist outside the context of HIV (e.g. Integrated 
Management of Childhood Illness) but “the science and evidence behind integration of PMTCT 
and MNCH services is still emerging” [2].  
Moving from global policy guidance to actual delivery of integrated care is a complex process. 
There are few published examples of programmatic approaches that effectively integrate 
PMTCT and MNCH.  Even less information is available to guide the process of designing such 
integrated programs at the service delivery level [3, 4].   
From 2007-2009, the GHESKIO Centers in Port-au-Prince, Haiti developed and implemented a 
pilot Infant Feeding Support Strategy (IFSS) among HIV-positive women and their children age 
6-12 months (Box 1).  The GHESKIO team is continuing to build on the pilot IFSS experience to 
develop a more fully integrated PMTCT and MCHN strategy that serves HIV-affected women 
and their children from antenatal care through the first 2 years of life.   
The objective of this paper is to share GHESKIO’s experience with development of an integrated 
PTMCT and MCHN strategy.  The aims of this paper are:  1) to define the problem that led to 
the development of the new IFSS, 2) to describe key contextual factors that influenced the IFSS 
design and how we attempted to address contextual barriers and 3) to identify key lessons 
learned from the pilot implementation and evaluation experience that can be applied to 
development of future integrated delivery strategies.  Implications for the next phase of PMTCT 
and MCHN integration at GHESKIO are discussed.   
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Box 1:   GHESKIO’s Infant Feeding Support Strategy  
The intervention was structured around delivery of age-targeted infant and young child feeding 
(IYCF) education through a “caregiver club” approach.  At enrollment, 6-month-old HIV-exposed 
infants were assigned to a caregiver club that included 8-12 infants within one month in age 
and their caregivers. Caregivers and infants came to the clinic every two weeks across the 24-
week intervention period.  Visits alternated between caregiver club meetings and individual 
appointments with a counselor.  Key messages from club sessions were reinforced at the 
individualized growth monitoring and counseling visits. Participants were given a daily ration of 
fortified lipid-based nutrient supplement (LNS) that provided 50% of dietary energy and a daily 
allowance of key micronutrients for the 6-12 month age group.  The IFSS promoted access to 
existing but underutilized GHESKIO clinic services including ORS, vaccinations, Vitamin A and 
household food rations [5].  The intervention pathways to impact growth outcomes are 
summarized in Figure 1. 
An evaluation of the IFSS among a pilot cohort of 72 HIV-exposed uninfected children was 
conducted from July 2008-August 2009.  Participation in the intervention was associated with a 
67.3% reduction in the prevalence of underweight and 54.7% reduction in the prevalence of 
stunting at age 12 months compared to same-age HIV-exposed children seen at GHESKIO in the 
previous year [5].  Growth effects of the intervention were not sustained 6-months post 
intervention.  By age 18 months, the prevalence of underweight and stunting were the same in 
the intervention and historical control groups.   
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DEFINING THE PROBLEM    
Poverty is an underlying problem that impacts every aspect of life in urban Haiti.  
Unemployment is 40.6% and two-thirds of Haitians do not have formal jobs.  Eighty percent of 
the population lives on less than US$ 2 per day [6]. Food insecurity is considered widespread 
[7]. Local agricultural production is not sufficient to meet national demand and urban 
households depend on purchase of imported products subject to global price fluctuations [8].  
The combined index for flour, oil and rice prices in Port-au-Prince increased 35% between 
January 2005 and December 2007, vastly exceeding general inflation [9].      
Haiti has the highest rates of infant, under-five and maternal mortality in the Western 
Hemisphere [10].  Among children under 5, the prevalence of underweight in Haiti is 19.2 %, 
stunting 30.1% and wasting 10.3% (WHO 2006 Growth Standards) [11].  Almost all Haitian 
mothers breastfeed but few do so exclusively.  Median duration of any breastfeeding in 
metropolitan Port-au-Prince is 14.5 months but median duration of exclusive breastfeeding is 
only 0.5 months [12].   Nearly 40% of Haitians have no access to primary health care [13].    
In the 1980s and 1990s, Haiti faced the most rapidly growing HIV/AIDS epidemic in the Western 
Hemisphere.  Through a coordinated national response that included early recognition of the 
epidemic by the Haitian medical community [14], efforts by the Haitian government and Red 
Cross to ensure safety of the blood supply [15] and scale-up of prevention and treatment 
services led by two large national Non-Governmental Organizations (NGO), HIV prevalence 
rates among pregnant women in Haiti fell from 9.4 % in 1993 to 3.7 % in 2003.  In 2007 
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prevalence in Haiti was 4.4% among pregnant women and 2.2 % among all adults age 15-29 
years old [16]. 
Founded in 1982, at the start of the AIDS epidemic, the GHESKIO Centers is a Haitian non-
governmental organization dedicated to clinical care, research and training in HIV/AIDS and 
related infectious diseases. GHESKIO’s primary outpatient clinical site is located in the center of 
Haiti’s capital city, Port-au-Prince, immediately adjacent to several of the city’s largest slum 
areas. The majority of clients come from urban poor communities in the greater Port-au-Prince 
metro area.  
GHESKIO is uniquely positioned in the Haitian health system.  It works in close partnership with 
the Ministry of Health and Population to develop evidence-based standards of clinical care for 
HIV, tuberculosis and other infectious diseases.   GHESKIO has received ongoing recognition for 
its contributions to national and global HIV policy [17].  In addition to two GHESKIO-run clinical 
sites in greater Port-au-Prince, GHESKIO provides training and supervision to a network of more 
than 20 partner clinics around the country.  Models of service delivery developed at the 
GHESKIO-run sites are adapted and scaled up to these national partners.   
In 2007, 2087 pregnant women were tested for HIV at GHESKIO’s downtown Port-au-Prince 
site.  Two hundred ninety (13.9%) of these women tested HIV-positive and were eligible for 
enrollment in the PMTCT program.   The GHESKIO PMTCT program provided a comprehensive 
package of medical services to HIV-infected women and their HIV-exposed children up to 24 
month of age.  In addition to routine pediatric clinic visits and childhood vaccinations, postnatal 
interventions included short-course ARV prophylaxis for mother and infant, HAART for women 
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with advanced HIV disease and all HIV-infected infants, early infant HIV diagnosis using PCR 
methods and antibiotic prophylaxis with cotrimoxazole for all HIV-exposed infants until HIV 
status was confirmed.  During pregnancy, PMTCT participants were counseled by nurses, social 
workers and physicians about options for feeding their children from 0-6 months including 
replacement feeding from birth with breast milk substitutes and exclusive breastfeeding with 
early weaning by 4-6 months of age to avoid mixed feeding.  
Driven by the desire to eliminate risk of MTCT through breastfeeding, GHESKIO leadership was 
committed to providing PMTCT mothers with the option of replacement feeding. Powdered 
infant formula was provided at no cost from birth to age 6 months to the more than 85% of 
PMTCT mothers who chose the replacement option [18] with no comparable support offered to 
breastfeeding mothers.  The GHESKIO support strategy for mothers choosing replacement 
feeding included appropriate quantities of infant formula, reinforced counseling about safe 
preparation, and access to pediatric clinical services.   GHESKIO strategy was based on the 2006 
WHO Consensus Statement on HIV and Infant Feeding which stressed the importance of infant 
feeding counseling support based on the individual mother’s situation and called for avoidance 
of any breastfeeding by HIV-infected women when replacement feeding was “acceptable, 
feasible, affordable, sustainable and safe ( AFASS)” [19].   
By 2008, MTCT at GHESKIO had reached the low rate of 5% at 18 months of age.  Mean weight-
for-age (WAZ) and length for age (LAZ) of HIV-exposed uninfected GHESKIO children improved 
steadily across the first 6 months of life suggesting the feeding strategy was adequate to 
support catch-up growth [5].   
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In contrast to the approach in place at GHESKIO for early infancy (0-6 months), there were no 
established protocols for infant feeding counseling or support for caregivers of HIV-exposed 
infants older than 6 months.   Because of financial constraints, it was not possible to continue 
provision of infant formula.  Available growth data suggested that GHESKIO infants were not 
making a healthy transition from infant formula to household-available foods.  WAZ and WLZ 
declined rapidly from 6-10 months, while LAZ faltering continued across the first 23 months of 
life.  Prevalence of underweight increased from 9.2% at 6 months to 17.1% at 12 months.  
Stunting increased from 13% at 6 months to 20.1% at 12 months [5].    Pediatricians described 
high rates of diarrhea across the 6-23 month period. Ninety-five percent of GHESKIO HIV-
exposed infants were not HIV-infected themselves and all children had access to high quality 
medical care, pointing to a primary problem of inadequate diet exacerbated by diarrhea and 
other common infections.   
The fundamental problem driving the IFSS design  was the need  to provide GHESKIO infants “a 
nutritionally adequate and safe diet without breast milk” [19] during late infancy.  WHO 
guidelines for feeding the Non-Breastfed Child between 6 to 24 Months of Age [20], stress the 
importance of providing other milks (e.g. animal milks, treated breast milk) or infant formula to 
meet the energy density and fluid intake needs normally provided by breast milk during this 
period.  Typically, children in developing countries obtain 65% of their calories from breast milk 
at 6-8 months of age, and 45% of calories at 9-11 months [21] – creating a large dietary energy 
gap if breast milk is not fed. 
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In the context of GHESKIO’s PMTCT program, infants of HIV-infected mothers were frequently 
forced to make a rapid transition from a milk diet (e.g. infant formula or EBF) to a diet with little 
to no animal milk.  In in-depth interviews with 11 PMTCT mothers, most reported having no 
consistent source of milk after the donated GHESKIO infant formula supply ended at 6 months. 
Many mothers were able to semi-regularly purchase a small quantity of tinned cow’s milk but 
infant formula was prohibitively expensive for all mothers.  In Haiti, as in many other HIV-
affected contexts, a month’s supply of formula costs about $40-70, far beyond the economic 
means of the population [22].   
IDENTIFICATION OF CONTEXTUAL FACTORS  
Not only did the IFSS need to meet dietary needs of non-breastfed children, but it had to be 
designed and delivered in the context of available resources, existing delivery structures and 
population-level factors. Some of the contextual elements were supportive but others created 
barriers to design and delivery which we tried to address as possible.     
1. Strong institutional commitment at GHESKIO to addressing nutrition care issues  
In mid-2007, GHESKIO partnered with the Division of Nutritional Sciences at Cornell University 
(Ithaca, NY, USA) to develop a strategy for nutrition care at GHESKIO.  The Cornell-GHESKIO 
team identified the gap in infant feeding support in late infancy as a priority action.  GHESKIO 
provided full support to IFSS design and implementation process.   The intervention design 
team was led by a doctoral candidate from the Cornell University Program in International 
Nutrition who had a background in community-based child survival programming.  
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2. PEFPAR mandate to integrate nutrition care  
GHESKIO’s PMTCT program was funded through PEPFAR.  PEFPAR issued a series of PTMCT, 
Orphans and Vulnerable Children (OVC), and nutrition-related guidance documents between 
2006-2007 that identified HIV-exposed children less than 2 years of age as a high priority group 
for targeted nutrition support [23-25].  The guidance called for integration of nutrition support 
into existing PTMCT and OVC interventions and linkages to broader maternal child health 
programs [23-25].  Haiti was one of several PEFPAR target countries identified for priority roll-
out of nutrition activities.   PEFPAR funds previously received by GHESKIO for OVC and PMTCT 
activities were immediately available to implement the IFSS.   
3. Growing body of evidence for IYCF intervention approaches outside the context of HIV 
The 2008 Lancet Series on Maternal and Child Undernutrition [26] identified a number of 
effective interventions for improving child health and nutrition outcomes. In food-insecure 
environments, provision of behavior change communication with a food supplement was a 
recommended approach to reduce risk of stunting and the burden of disease in children 6-24 
months of age [26]. Factors influencing the impact of IYCF interventions include the baseline 
health and nutritional status of the target population, timing of initiation and duration of 
intervention [27-30].  In their 2008 review of complementary feeding interventions in 
developing countries, Dewey and Adu-Afarwuah examined a range of program models targeting 
6-24 month olds and characterized the overall effect size for such interventions on growth as 
“modest”  but noted that “optimally designed and implemented” programs had greater 
potential for impact [30].   
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The 2005 WHO Guiding Principles for Feeding Non-Breastfed Children age 6-24 Months [20] 
provided guidelines for key messages of IYCF interventions in non-breastfed population.  In 
addition to increasing the energy density and micronutrient quality of the infant’s diet, effective 
complementary feeding interventions promote positive maternal feeding practices (e.g. 
frequent feedings, responsive feeding, feeding during illness) and food safety (e.g. hand 
washing, clean water, proper food storage) [27, 28].   
The IFSS design team visited several community-based health programs in rural Haiti that used 
participatory group-based approaches for IYCF education [31-34].  Published descriptions of 
clinic-based programs were available from Brazil [35] and Peru [36, 37].  
4. Commitment to local foods but limited quality options available  
GHESKIO was committed to using a locally-produced and procured supplementary food that 
met several key criteria related to the target population. The supplement needed to a) be 
energy dense and appropriate for child’s small gastric capacity and developmental stage, b) be 
micronutrient fortified due to lack of animal source foods in diet, c) require little to no cooking 
due to shortages of cooking fuel and caregiver time, and d) meet food safety standards without 
refrigeration.    
PEFPAR guidance [38] allowed for purchase of supplementary foods for HIV-exposed children 
with PEPFAR funds when other donor sources (e.g. World Food Program) were not available.  
The challenge in designing the IFSS was choosing a supplement option that met both the 
intervention needs and expectations of PEFPAR.   
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In 2007-2008 there were several locally produced flours cereal products commonly used for 
infant feeding in Haiti including a) flours made from local tubers/root vegetables (e.g. plantain 
flour, manioc flour), b) Akamil, a flour composed of mixed grains and legumes, developed in 
rural Haiti in the mid-1970s for treatment of malnourished children and c) Nourisoy, a fortified 
soy flour produced by a local pharmaceutical firm that was marketed for feeding children.  
None of these flour-based options was appropriately fortified, all required addition of milk to 
reach energy density targets, and all required between 20-60 minutes of cooking time.   The 
only locally available product that met GHESKIO’s requirements was “Medika Manba,” an 
energy-dense fortified lipid-based nutrient spread (LNS) produced in Haiti by a local NGO.  The 
NGO was able to produce a version with micronutrient fortification levels that matched the IFSS 
requirements.   
However, the LNS did not initially meet PEFPAR’s expectations.  The PEFPAR “Food by 
Prescription” policy developed in Kenya promoted the use of cereal-based supplementary food 
products only for prevention programs and reserved LNS (e.g  Plumpynut) for treatment of 
severe malnutrition [39].  After several months of effort that contributed to a delay in IFSS 
implementation, GHESKIO was able to negotiate with USAID Haiti for the use of the LNS in the 
pilot implementation. PEPFAR funds were used to purchase the LNS product.   
5. Participants’ chaotic life circumstances 
Urban poor HIV-infected Haitian mothers faced a unique combination of circumstances that 
create barriers to caring for their children effectively  and to accessing available support 
services.  Provision of the LNS as part of the IFSS addressed some of the food-access related 
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barriers associated with poverty and household food insecurity.  The greater challenge to IFSS 
design was working within the chaotic contexts created by the caregivers’ personal and 
household situations. 
Stigma around HIV/AIDS remains high.  Due to stigma, mothers sought to maintain secrecy 
around their HIV status secret.  In our pilot cohort, only 40% of mothers said that another 
person in their household was aware of their HIV status.  Mothers often felt the need to lie to 
their partners and other household members about the source of the IFSS supplement.  To 
address this barrier, no IFSS-related supplies given to the caregivers (e.g. child growth card, 
supplement) had any GHESKIO-related identifiers or markings.  Several mothers had  highly 
supportive partners, family members or friends who would accompany them to their visits and 
provide child care.  Even with these individuals, GHESKIO staff did not assume they knew about 
the mother’s HIV status and would tailor their interactions with the mothers accordingly.   
Mothers were frequently not the primary caregiver of their children.  Among the 30.1% of 
women in the pilot cohort who had paid employment in the previous year, most worked as 
market vendors or live-in housekeepers for higher-income households.  In Haiti children are not 
brought with mothers who work in these settings.   Day-to-day caregiving responsibilities often 
fall to adult relatives, neighbors, older siblings or hired help. Often, these individuals are not 
aware of the mothers’ HIV status making it difficult to target them as part of a PMTCT program.  
Custody disputes related to the breakdown of informal partnerships were another reason why 
mothers were not the primary caregivers of their children.  Three of the 82 women in the pilot 
intervention cohort lost custody of their children for different durations of time because of the 
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breakdown of their informal partnerships.  The IFSS addressed these situations on a case-to-
case basis to the extent feasible.  In one example, the GHESKIO counselor advised a mother 
who usually sold goods in the market to instead sell from the street in front of her own home 
so she would be available to care for her child.  The strategy worked for that particular mother.  
Other working mothers were encouraged to bring the child’s primary caregiver to the club or 
individual sessions if it did not risk disclosure of the mother’s status.  In two of the cases with 
estranged partners, the GHESKIO counselor was involved in facilitating discussions between the 
parents and was able to negotiate return of the children to the mothers’ care.   
Mothers experienced social isolation. With the trend towards urban migration, many GHESKIO 
caregivers lived long distances from extended family who are still in distant rural areas.  
Caregivers would often send their children to family in rural areas while they stayed in the city. 
Again the IFSS team dealt with these situations on a case-by-case basis.  Mothers were allowed 
to come to a visit without the child occasionally and still participate in club sessions.  Mothers 
were encouraged to keep children with them to the extent possible.  
Volatile socio-political situation lead to public unrest and some violence.  Poor governance and  
economic hardship have contributed to elevated levels of violence in urban areas.  A United 
Nations Stabilization Force has been present in Port-au-Prince and surrounding provinces since 
2004. According to a 2006 World Bank report, 58% of residents in metropolitan areas  felt 
unsafe in their own homes “often or most of the time” compared to 15% in rural areas [13].  An 
estimated 35% of women over the age of 15 in Haiti have been victims of physical violence [13]. 
The first half of the intervention period was notable for widespread protests related to 
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increasing food prices in April 2008, some of which were violent. Caregivers would miss IFSS 
visits if general insecurity levels were high because public transport was usually unavailable and 
people were afraid to be the streets.   The IFSS program had to accommodate these 
circumstances by allowing individuals to join other clubs or make up visits on a case-by-case 
basis.  Fortunately such periods rarely lasted more than 1 to 2 days at a time.       
Variable access to services outside of GHESKIO.  It is difficult to assess what health services or 
social programs GHESKIO-enrolled caregivers received outside of GHESKIO.  Government-led 
social aid programs were not generally available but there are a number of local and 
international NGOs implementing health and development programs in and around Port-au-
Prince.  Only six caregivers participating in the pilot intervention reported receiving food 
support (including infant formula) from a source outside GHESKIO.  GHESKIO does not limit 
participation based on access to other services so it is possible that some participants were 
receiving duplicate care.  Although children with complicated cases of severe acute 
malnutrition were referred to the government or NGO-run hospitals for inpatient care, it was 
not possible to depend on availability of other external referral services in the IFSS design.   
6. Delivery  context at GHESKIO  
In 2007-2008 pediatric clinical care at the GHESKIO Centers was considered part of the 
“GHESKIO Integrated Model of Care” that used HIV counseling and testing as a gateway to 
connect clients to other on-site services including treatment of HIV and other sexually 
transmitted infections, tuberculosis diagnosis and treatment, reproductive health and family 
planning services, psychosocial support and a microcredit program.  At the time, the model was 
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“integrated” in the sense of identifying needs for multiple services in an individual client and 
then delivering services through visits to separate units within GHESKIO (e.g. pediatrics clinic, 
family planning clinic, sexually transmitted infection clinic, etc).  An HIV-infected woman might 
have to return to the GHESKIO site several times over multiple days in order to receive all the 
“integrated” services for her and her child.   
GHESKIO faced a shortage of health workers common in many less-developed countries [40].  In 
2007-2008, the GHESKIO pediatrics clinic faced a period of higher than usual staff turnover and 
several periods of understaffing.  Given this situation, it was not possible to add IFSS 
responsibilities to those of existing staff members.  
Prior to the launch of the IFSS, GHESKIO had little experience with the community-based 
models for delivering preventative health care services that are fairly common in parts of rural 
Haiti (e.g. “rally posts” for growth monitoring and counseling, use of community health agents) 
[31, 32, 41].  As a referral site focused on HIV-care, GHESKIO draws clients from across a 
relatively wide-spread metropolitan area.  Because of security concerns and logistical 
constraints, all intervention delivery activities had to take place on the GHESKIO site rather than 
in the household.  Part of the motivation for using the caregiver-club model was to bring some 
of the positive elements of these generally community -based approaches into the clinical 
context.   
Despite operating in an extremely unstable context, GHESKIO had never suspended HIV-
treatment services.  This required constant contingency planning to ensure continuity of care 
and an extremely dedicated staff team to flexibly implement those plans.  GHESKIO was also 
fundamentally committed to providing all services at no cost to clients. Any intervention 
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needed to be fully supported through resources from donors like PEPFAR or other 
implementing partners.   
LESSONS LEARNED  
1. Integration at service delivery level must be driven by the needs of the end users   
As PEPFAR 2011 guidance notes, “Integration is not an end or objective but a means to achieve 
more effective and efficient service delivery”  [2]. For integrated programs to be successful, the 
full package of services should reach the end users.  Services must be structured to reflect their 
reality.  As highlighted above, it should not be assumed that poor mothers do not have 
competing priorities for their time and resources.   
The IFSS was “integrated” in terms of combining education and supplementation activities into 
a single intervention, but in the pilot phase, intervention delivery was, similar to the broader 
GHESKIO model, in addition to routine pediatric clinic visits.  Participation in the IFSS pilot 
cohort added 1-2 additional visits to the GHESKIO site per month for each caregiver. For 
working caregivers or caregivers who lived a significant distance from the clinic, the opportunity 
cost of additional visits to the GHESKIO site was very high.  Although not formally measured, it 
was clear to the IFSS team that some participants missed scheduled visits to the pediatric or 
PMTCT clinics to attend the IFSS visits.  
Delivery of some services including distribution of oral rehydration solution (ORS) and Vitamin A 
through the IFSS team resulted in improved overall coverage rates for these services.   
However, lack of full integration created further inefficiencies in service delivery.  For example, 
68 
 
the IFSS team had to refer children missing vaccinations back to the pediatrics clinic where they 
would not necessarily receive the vaccine post referral.   
Looking ahead:  For the next phase of implementation, GHESKIO has modified both pediatric 
clinical protocols and the IFSS caregiver club model to achieve more complete integration of 
service delivery.  It was not possible to integrate one service fully into the other – both needed 
to change.  In the more fully integrated model, caregivers and infants will receive all preventive 
health services (e.g. growth monitoring,  infant feeding counseling, vaccinations, vitamin A, 
distribution of food supplements, family planning services, etc) through monthly (age 0-12 
months) or bimonthly (age 11-24 months) caregiver club meetings.  Children will no longer have 
routine visits with the pediatricians or regularly scheduled individual visits with the IFSS team. 
Clinical triage will be done by a nurse practitioner during caregiver club meetings and 
complicated cases will be referred to pediatricians only as necessary.  Eventually the model will 
be scaled up to include HIV-positive pregnant women.   
2. Group-based strategies provide a channel for delivery of integrated services with added 
benefit of social support  
In many ways, a more individualized service delivery model would have been easier to 
coordinate in the GHSEKIO population.  Development of the caregiver club strategy required 
significant investments of staff time to set up meeting schedules and initial enrollment 
protocols.  It was a challenge to make adjustments around holidays and unscheduled 
interruptions due to civic unrest and natural disasters.  The caregiver club model required a 
meeting space that was large enough to hold a group of a group 15 adults and their children 
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with some degree of privacy. Space at GHESKIO was at a premium and the room used for IFSS 
was not ideal.  The space was very small and connected to the administrative sector of the 
GHESKIO site rather than near the pediatric and PMTCT clinics.  However both IFSS staff and 
participants were accommodating of these limitations.   
Investments were worth the effort as the caregiver club strategy allowed for efficient delivery 
of participatory education and distribution of commodities.  Furthermore, the caregivers club 
approach generated social support by fostering friendships between HIV-infected women 
facing similar circumstances.  These friendships extended beyond the caregivers club meetings.  
Mothers reported communicating with one another outside of the clinic and arranging other 
GHESKIO visits at similar times. During exit interviews from the pilot cohort, all mothers 
expressed preference for the group sessions over individual counseling sessions (Box 2).  
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BOX 2:  Illustrative quotes from exit interviews with participating caregivers (n= 72)  
• Caregivers prefer group sessions – mothers clubs are a source of social support 
“We have become friends with one another” 
“I can share my experiences with them” 
“We sit and talk together” 
“I would rather come with other mothers, it’s more interesting” 
• Program participation cam impact the caregiver’s personal wellbeing. 
“When I first came I was very discouraged, now I have hope” 
We love our children more now than we did before” 
• Positive relationship between caregivers and staff team 
“They always have a smile.  They joke with me.” 
“When they do not see me, they ask for me.” 
“They love children.” 
“They do not judge people by appearances.  All people are people.” 
Looking ahead:  The caregiver club model is the backbone of the expanded PMTCT and MCHN 
strategy that will include all children 0-24 months and eventually, pregnant women.  As the 
number of participants increases, it will be essential to maintain a manageable group size that 
can continue to foster interpersonal relationships.  Implementation models such as the “Care 
Group” approach used in community-based child survival programming [42, 43] combine small-
group and peer educator methods with group-based training and supervision and effectively 
leverage a small number of paid staff.  This may work for the GHESKIO program as it grows. 
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3. Delivery of integrated services among chaotic populations requires a skilled, motivated 
and flexible staff team 
The four staff members who formed the IFSS pilot implementation team, a lead nurse-
counselor, an auxiliary nurse-counselor and two program assistants, were experienced and 
motivated individuals.   They had a genuine concern for and connection to the caregivers and 
infants in the program.   The lead nurse would regularly drive to and from work along a route 
where she knew a homeless mother in the pilot cohort tended to stay in order to stay aware of 
the vulnerable mother’s situation.  The nutrition counselor traveled an hour to and from her 
home on her weekend time off in order to find a mother who missed her visit because her 
husband had been incarcerated. These qualities are not as exceptional as one might think –
commitment to healing, professional satisfaction, positive interpersonal work environments, 
and non-financial recognition for accomplishments are often stronger motivators than financial 
incentives among health workers in both high and low income countries [40, 44].   
The IFSS team was intentional about “staff care” – fostering an environment where staff felt 
encouraged and empowered as they worked with a very challenging population.  Team 
members were expected to put in full 8-hour work days but were not required to work 
overtime.  The team held regular formal and informal meetings during which team members 
were encouraged to talk about the situations they encountered and suggest modifications to 
improve IFSS delivery.  
The caregiver club model allowed staff to engage with participants on a more personal level but 
that in turn, added an element of stress for the staff.  It was challenging for them to confront 
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participant needs continually and have relatively limited tangible goods and services to offer 
them.  In response, core IFSS protocols were clearly defined and club sessions were highly 
structured but staff were encouraged to indentify individual participants who required 
additional investment and adapt a follow-up plan for them.  Staff were given flexibility to offer 
small incentives (e.g. additional ORS packets, transport fees) to special needs caregivers based 
on their own discernment.  
 Looking ahead – The further integration of MCHN and PMTCT services will require GHESKIO 
staff to play expanded roles. Mothers will no longer be referred to a family planning counselor 
for family planning commodities or to the pediatric nurse for vaccinations.  All of these 
functions will be completed by a small team of staff who are each able to carry out a number of 
these functions.  In urban Haiti, unlike some other contexts, it is not so difficult to find 
individuals with the necessary skills. However, in an environment where people have previously 
defined their roles by a more narrow set of tasks it can generate tensions as one group “steps 
into” another’s “territory.”  Continuing education and social support for the staff members will 
be important to maintain motivation.   
4. Delivery of integrated programs requires compromise by internal and external 
stakeholders 
Compromise is essential in the development of an integrated service delivery model. 
Practitioners from different disciplines often have different values and priorities.  In 2007, when 
the GHESKIO IFSS model was first being developed, the team from Cornell’s Division of 
Nutritional Sciences had to respect the fundamental value placed on supporting a replacement 
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feeding option by GHESKIO leadership.  The decision to use a locally-produced LNS was a 
compromise with PEPFAR policy based on GHESKIO’s fundamental commitment to supporting 
local production.  Delivery of integrated programs is more likely to require inputs from several 
different donor sources. PEPFAR promotes use of their funds for “wrap-around” programs that 
supplement activities supported by other donors [23-25]. Donors will not necessarily share the 
same goals and objectives.  They often have different timeline and reporting requirements.  
There needs to be compromise on both the level of the donor and the implementer to enable 
integrated programs to move forward.   
Looking ahead:  Development of the new strategy will require ongoing compromise on 
mulitiple levels.  For example, in the pilot GHESKIO IFSS model, physicians continued to conduct 
all well-baby visits.  In the new model these tasks will be carried out by an advanced practice 
nurse.  For the new model to succeed physicians must be willing to relinquish some of their 
established role. 
5. Integrated programs require evaluation designs that can assess the contribution of 
various components to overall outcome   
A challenge in the evaluation of integrated strategies is to identify which elements of the 
intervention have contributed to the overall impact.  In the pilot evaluation of the IFSS we used 
a program-theory guided approach (Figure 1) [45, 46]. The non-randomized design included 
measures of compliance and changes in IYCF knowledge and reported caregiver behaviors.  Our 
evaluation design was not intended to assess the relative contribution of each pathway but 
provided reasonable evidence that the intervention did follow the postulated pathways [46].  
The evaluation included exit interviews with participants that helped identify unintended 
 consequences of the intervention
and negative (e.g. mothers missing their own clinic visits to attend IFSS visits) 
FIGURE 2.1  The pathway between infant feeding suppor
growth outcomes among intervention participants.   Width of arrow reflects the 
assumed relative contribution of the activity to improved growth outcome 
compared to the other intervention activities.  
feeding,  CG=caregiver, FM = fortified manba supplement
 
Looking ahead:  GHESKIO will continue to integrate 
strategies in the more integrated PMTCT and MCHN strategy.  
important consideration to address in evaluation of the expanded model.  
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CONCLUSION 
Many of the contextual factors influencing the development and implementation of an 
integrated PMTCT and MCHN program at GHESKIO are shared by PTMCT programs in sub-
Saharan Africa and other developing country contexts.  Lessons learned from the GHESKIO 
experience can be applied and evaluated in these contexts in order to further our global 
understanding of how to achieve effective integration at the service delivery level.  The learning 
is ongoing at GHESKIO where the delivery context continues to evolve in response to the  
devastating January 2010 earthquake and a gradual shift in GHESKIO infant feeding policy to 
support breastfeeding by HIV-positive mothers on ARV [47].   
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CHAPTER 3 
GROWTH OF HIV-EXPOSED UNINFECTED CHILDREN IN URBAN HAITI 
ABSTRACT 
Little is known about the postnatal growth patterns of HIV-exposed uninfected children in low-
income countries who receive PTMCT interventions.   We describe the growth pattern of 360 
HIV-exposed, uninfected children under age 23 months who received PTMCT care at the 
GHESKIO Centers in Port-au-Prince, Haiti between July 2007 and October 2009.   Longitudinal 
data on weight, height and other exposures were collected from GHESKIO medical records and 
growth indices were calculated using the WHO 2006 Growth Standards.  Growth outcomes in 
HIV-exposed uninfected GHESKIO children were compared to a nationally-representative cross-
sectional sample of 1190 children age 0-23 months from the 2005-2006 Haiti Demographic 
Health Survey.   
GHESKIO infants were born at very low mean LAZ (-1.31 ± 1.67 SD) but normal WLZ (0.21 ± 1.47 
SD).  Prevalence of LBW (14.6%) and stunting at birth (40.0%) were high.  Although smaller at 
birth, mean WAZ (-0.35  ± 1.19 SD) and LAZ (-0.56 ± 1.41 SD) at age 6 months in GHESKIO 
infants were not different from the DHS sample.   LAZ and WAZ declined in both populations 
from 7 to 23 months, but were significantly higher in GHESKIO infants at 23 months.   There was 
no difference in mean WLZ or prevalence of wasting between the two groups at any age.  
Within GHESKIO children, variables related to in utero HIV exposure and access to clinical care 
were significantly associated with birth size and growth outcomes in the 0-6 and 7-23 month 
periods. 
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Findings suggest that HIV-exposed uninfected infants receiving PMTCT services were born very 
stunted and demonstrated catch-up growth from birth to 6 months of age.  Additional research 
is needed to understand the causes of in utero stunting and subsequent growth pattern in early 
infancy.  GHESKIO children had better WAZ and LAZ outcomes in late infancy compared to the 
general Haitian population.  This may reflect a disparity in medical services related to the 
intensive targeting of funding and services to HIV-affected populations compared to the general 
population in Haiti.   
INTRODUCTION 
Over the last decade, there has been a dramatic increase in funding for interventions targeting 
the 1.4 million HIV-infected pregnant women living in low- and middle-income countries [1-5].  
Since the early 2000s, advances in prevention-of-mother-to-child transmission (PMTCT) 
programs have reduced HIV transmission rates from 15-35% without intervention [6] to 2-5%  
with an intervention package that includes treatment with highly active antiretroviral therapy 
(HAART) for pregnant women with advanced HIV disease, short-course antiretroviral (ARV) 
prophylaxis for HIV-exposed infants and less advanced maternal cases, and support for safer 
infant feeding [7-9].   
Growth is a composite indicator of the health status of a young child. It reflects the combined 
effects of genetic potential, in utero conditions, dietary intake, illness, access to care and other 
environmental exposures [10].  Regardless of the HIV-status of the mother, infants and young 
children in low income countries are at risk of poor growth [11, 12] and survival outcomes [13, 
14].  Undernutrition is the underlying cause of 35% of deaths in children under 5 [11]. 
Intrauterine growth retardation (IUGR) or stunting in the first two years of life is associated with 
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negative health and economic consequences in infancy and continuing into adulthood [15].  For 
these reasons, prevention of early childhood malnutrition is a high priority for child survival and 
global development.   
To date, evaluations of PTMCT interventions in low-income countries have focused on infant 
HIV transmission, morbidity and survival outcomes.   Much less is known about the postnatal 
growth patterns of infants who receive the current standards of PMTCT care [16, 17].  In a 2009 
review, Insanaka et al [17] concluded that there is “little evidence” that the postnatal growth of 
HIV-exposed uninfected infants is different from unexposed controls. The review included 15 
longitudinal studies conducted among children under 23 months old from developing countries.  
However, only one of the fifteen studies involved a population recruited after 1999 , the year 
when PMTCT interventions first became available [17].  Potential pathways by which PMTCT 
interventions could impact the postnatal growth of HIV-exposed uninfected children include in 
utero exposure to ARVs, postnatal exposure to cotrimoxazole prophylaxis, HAART-related 
changes in caregiver health and wellbeing, altered infant feeding practices (e.g. formula, heat-
treated breast milk, early weaning), and access to other preventative health services offered in 
conjunction with PMTCT.   
Four published studies conducted after the year 2000 report longitudinal growth outcomes for 
HIV-exposed uninfected children in sub-Saharan Africa [18-21].  All four studies included short-
course ARV prophylaxis for the mother.  Results are difficult to compare among studies due to 
differences in the overall clinical standard of care (e.g. access to HAART, cotrimoxazole 
prophylaxis), duration of follow-up, and reported growth outcomes (e.g. different reference 
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populations were used to standardize growth measurements).  Authors of one of the two 
studies that compared HIV-exposed uninfected infants to unexposed infants concluded that  
early WAZ and LAZ growth patterns were different in the two groups [21]. The other concluded 
there was no difference in WAZ between HIV-exposed uninfected and unexposed children from 
0-24 months [19]. 
Most published studies from low-income countries that compare early postnatal growth in HIV-
exposed uninfected versus unexposed children involve prospective cohorts in which both HIV-
exposed and unexposed infants received higher quality medical care than what is likely 
available to the general public [19, 21-26].  For policy purposes, it can be useful to include a 
comparison group who receive the locally-available standard of care.  In 84 countries 
worldwide, nationally representative, cross-sectional growth data for children under 23 months 
are collected as part of the Demographic Health Survey (DHS), a household survey focused on 
maternal child health outcomes.  Data are available for public use [27]. 
The primary aims of this study were to 1) describe average growth patterns from birth to age 23 
months of HIV-exposed, uninfected children who received a package of PMTCT interventions 
and infant feeding support as part of routine care at Groupe Haïtien d’ E´tudes du Sarcome de 
Kaposi et des Infections Opportunistes (GHESKIO) in Port-au-Prince, Haiti and 2) identify factors 
associated with the observed growth outcomes.  The secondary aim is to compare growth in 
GHESKIO children to the nationally representative 2005-2006 Haiti DHS.   
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METHODS 
GHESKIO Participants 
Primary study data were collected from outpatient medical records at GHESKIO, a Haitian non-
governmental institution dedicated to clinical care, research and training in HIV/AIDS and 
related infectious diseases.   GHESKIO’s primary site for HIV voluntary counseling and testing 
and clinical care is located in downtown Port-au-Prince adjacent to several of the city’s largest 
slum communities.  
We included available growth data for all confirmed HIV-exposed, uninfected children age 0-23 
months seen in the GHESKIO pediatric clinic between 1 July 2007 and 15 October 2009.   A child 
was classified as HIV-exposed if the child’s enrollment record was linked to a PMTCT-enrolled 
mother.  Children without PMTCT-linked records were classified as HIV-exposed if they had a 
positive HIV antibody test result prior to age four months when maternal HIV antibodies are 
still detectable in HIV-exposed offspring.  A child was classified as HIV-infected if there were 
two positive PCR or P-24 antibody test results for the child [28]. 
GHESKIO standard of care 
GHESKIO’s PMTCT program was launched in 1999 to reduce the risk of HIV transmission and 
decrease mortality in infants born to HIV-infected mothers [8, 29]. The rate of mother to child 
HIV transmission at the time of the study was estimated to be less than 5% [8]. 
Starting in 2006, GHESKIO used the Haitian Ministry of Health and Population’s (MOHP) multi-
tiered PMTCT ARV prophylaxis protocols based on stage of maternal disease and timing of 
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presentation to prenatal clinical care.  HAART was provided to all HIV-infected pregnant women 
with advanced disease (CD4<250cells/μl or WHO stage IV). Short-course perinatal monotherapy 
with zidovudine (AZT) starting at 28 weeks of gestation was provided to pregnant women who 
did not meet WHO eligibility criteria for HAART. Lamivudine (3TC) was added to the regimen of 
mothers presenting after 36 weeks gestation.  Starting within 72 hours after delivery, infants 
were given AZT for 1 or 6 weeks with or without one-week of 3TC depending on maternal 
regimen. 
HIV-positive women who enrolled in the PMTCT program during pregnancy were counseled 
about options for infant feeding.  At the time of the study, these included replacement feeding 
from birth with artificial milk or exclusive breastfeeding with early weaning encouraged by 4-6 
months of age.  PMTCT-enrolled mothers who chose replacement feeding received powdered 
infant formula at no cost for the first 6 months of infancy.  At the time of this study, 85-90% of 
all HIV-exposed infants at GHESKIO were replacement fed from birth [8, 29]. 
A team of GHESKIO clinicians provided well-baby and sick-child care to all HIV-exposed children 
under 23 months of age including children who enrolled at GHESKIO after delivery and did not 
participate in the GHESKIO ARV prophylaxis intervention.  Children received the MOHP 
vaccination package (BCG, polio, DPT, measles) and high-dose vitamin A supplementation.  
Measles vaccine was given at 12 months of age. All HIV-exposed infants received cotrimoxazole 
from birth until HIV-negative status was confirmed.   Pediatric HAART was provided to all 
confirmed HIV-infected infants [30]. 
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A small number of children during the study period participated in a pediatric research trial 
(AIDS Clinical Trials Group Protocol 5207) that randomized HIV-infected pregnant women at 
delivery to a one-week or three-week regimen for postnatal ARV prophylaxis.  Children of the 
5207 trial participants received more intensive clinical follow-up in the second half of infancy 
than other GHESKIO infants and no-cost infant formula until 12 months of age. 
GHESKIO data collection 
All data were collected through a structured chart review of GHESKIO’s electronic and paper 
medical records.  Available variables were limited to those routinely collected at initial GHESKIO 
enrollment and pediatric clinic visits.  
Demographic variables.  The GHESKIO enrollment database included basic demographic data 
for all participating infants including enrollment date, gender, birth date and HIV-status.  
Maternal education level was available for all infants whose records included their mother’s 
GHESKIO enrollment identification number. 
Birth weight. First available weight within 7 days of birth was extracted from the paper chart or 
when available, the referral form from the hospital where infant was delivered.  First available 
weight was captured regardless of whether the visit was before or after 1 July 2007. 
Postnatal growth. All available growth data for each child up to age 24 months collected after 1 
July 2007 were captured.  Research-quality digital infant scales (Tanita 1583, Tokyo, Japan) and 
infantometers (Easy-Glide Bearing Infantometer, Perspective Enterprises, Portage, MI) were 
introduced to the pediatric clinics as of July 2007 along with staff training in anthropometric 
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measurement.  Child growth (length and weight) were measured by pediatric nursing staff at 
every clinic visit and recorded in paper medical chart.  Length was measured in recumbent 
position to the nearest 0.1 cm and weight was measured to 0.01 kg. Clinic staff received routine 
refresher training on measurement techniques.   
In utero environment. In utero exposures were assessed using indicators of maternal HIV 
progression (CD4 cell count), treatment access (HAART) during pregnancy and birth weight.  We 
collected the maternal CD4 count result during pregnancy that was closest to the child’s 
delivery date from the PTMCT clinic records of all identifiable mothers.  Data of initiation of 
HAART treatment in HAART eligible mothers was also extracted.   
Access to care. We considered timely completion of short-course perinatal ARV prophylaxis and 
scheduled infant vaccinations as indicators of access to clinical care. Completion of ARV 
prophylaxis was available in the clinical record of all infants whose mothers enrolled in the 
GHESKIO PMTCT program during pregnancy. We extracted the data on vaccine and vitamin A 
supplementation  recorded by pediatric nurses in child’s paper chart for all children eligible to 
receive the vaccine.   Children were considered eligible if they had 1) a vaccine chart in their 
paper medical record and 2) at least one documented clinic visit after the age scheduled to 
receive the vaccine (BCG at birth, DPT3 at 6 weeks, measles at 12 months, vitamin A starting at 
6 months).  As described previously, participants in the 5207 trials had access to an augmented 
package of clinical care and infant feeding support.  Data on 5207 trial participation was 
collected from the GHESKIO enrollment database.    
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The study protocol was approved by IRBs at GHESKIO (Port-au-Prince, Haiti), Cornell University 
(Ithaca, NY, USA) and Weil Cornell Medical College (New York, NY, USA). All personal identifiers 
were removed from data before analysis.     
DHS data 
The 2005-2006 Haiti DHS Survey IV [31] included women of reproductive age 15-49 years and 
children under 5 years from 9998 households selected in a 2-stage stratified cluster sampling 
design from the 10 administrative departments and the metropolitan area of Port-au-Prince.  
Weight and length measurements were collected for all children 23 months and younger in 
participating households [32].  Data about HIV-exposure was not available for children in this 
analysis, however HIV prevalence was estimated at 2.2% nationally.  Permission to use the DHS 
dataset was obtained from MACRO International (Calverton, MD, USA).   
Statistical analysis 
To describe the average growth pattern from birth to age 23 months of HIV-exposed uninfected 
children at GHESKIO, birth weight data were analyzed separately from data on subsequent 
postnatal growth.  Mean growth outcomes by age group were calculated in two ways.  First we 
used a cross-sectional approach and then we developed models to identify variables associated 
with growth across the study period that accounted for repeated measures on individual 
children. 
Size at birth. Mean birth weight and prevalence of low birth weight (LBW) (birth weight < 2500 
g) were calculated using earliest available weight from the first 7 days of life.  It was not 
possible to calculate a birth weight z-score given the lack of complete data on gestational age 
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[33].  The association between birth weight and infant and maternal characteristics was 
assessed using a Generalized Linear Model (GLM) with birth weight in kilograms as the 
outcome.  Variables significant at p<0.2 in the single variable GLM were included in the 
multivariable GLM.  Although the total number of children with available data on gestational 
age at birth was quite small, we chose to run multivariable GLM with and without available 
preterm data given the strong correlation between preterm delivery and birth weight.   
Postnatal growth. Weight-for-age (WAZ), length-for-age (LAZ) and weight-for-length (WLZ) z-
scores were calculated using the WHO 2006 Child Growth Standards [34].  Individual z-scores 
were calculated using age in days and grouped by completed month ± 15 days. If more than one 
z-score was available for a child during the one-month period, the mean of all available z-scores 
was used.  Cross sectional mean WAZ, LAZ, and WLZ by month of age were then calculated for 
the entire sample.   
Infant and maternal determinants of growth from 0-23 months were assessed by fitting multi-
level models for change controlling for child age at visit. The SPSS 19 MIXED procedure with 
random intercept and random slopes accounts for repeated measures on individuals and allows 
for irregularly spaced measurements
 
and missing values across individuals.  It includes 
estimates of the within and between individual error terms.  Separate models were fitted by 
period (0-23 months, 0-6 months, 7-23 months) using each growth variable (WAZ, LAZ, WLZ) as 
the outcome.  Single variable models were developed to test the association between each 
infant or maternal variable and the outcome while controlling for the effect of child age.  All 
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variables with p-value <0.1 in single variable models were then included in a multivariable 
model to test their combined effects on the designated outcome.   
The same approach described above for GHESKIO data was used to calculate WAZ, LAZ, WLZ by 
age category in the DHS sample.  Independent sample t-tests were used to compare mean 
growth outcomes for each age category in GHESKIO children compared to DHS children. 
Prevalence of growth faltering by age group was compared between groups using Chi-Square 
analysis. 
All statistical analyses were performed using SPSS Version 19 (SPSS Inc., Chicago, IL)  
RESULTS 
Four hundred ninety six GHESKIO children met the criteria for confirmed HIV exposure. Children 
were excluded if they did not have a paper medical chart containing growth data from at least 
one clinic visit before age 2 years (n=67) (Figure 3.1).  Children with positive or indeterminate 
HIV test results were excluded (n= 69).  A total of 3700 observations from 360 GHESKIO children 
were included in the analysis.  There was a large amount of variability in the timing and total 
number of visits completed by each child [median (IQR) visits per child = 10 (4.25, 14)].   
 
 
  
93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Flow chart describing the process of identifying GHESKIO child                           
records for inclusion in chart review   
  
Children with at least 1 clinic visit after 1Aug 2007 
(n=1200) 
Children born to confirmed HIV-infected mother 
(n=496) 
Children with available paper chart with growth data 
(n=429) 
Confirmed HIV-exposed uninfected children included in analysis 
(n=360) 
2883  No visit after 1 Aug 2007  
168  Confirmed not HIV-exposed 
29 No infant HIV test   
507 Uncertain HIV exposure  
43 Enrolled after age 23 mo 
24 No paper chart   
22 Child HIV-infected 
47 Child HIV status indeterminate   
All children enrolled at GHESKIO with date of birth between  1 
Aug 2005 to 19 Dec 2007 
(n=4083) 
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Table 3.1 describes demographic and health characteristics of the GHESKIO population. Data on 
preterm delivery and early infant feeding method were incomplete in the clinical medical 
records and are therefore not reported.  However we know that the vast majority (>95%) were 
predominantly formula fed.   
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Table 3.1 Characteristics of HIV-exposed uninfected GHESKIO children included in the analysis 
(n=360) 
  N
*
 % 
Infant characteristics  
Female gender  360 49.2 
Live in province / rural community 360 5.6 
Median age GHESKIO enrollment (IQR) - days  360 19 (55) 
PMTCT participant 360 84.4 
 Enrolled in 5207 protocol 360 5.6 
 Completed PTMCT prophylaxis regimen 302 76.5 
Vaccine chart available 360 93.9 
 Received BCG  338
‡
 93.2 
 Received DPT 3rd Dose 330
‡
 86.7 
 Received Measles 307
‡
 77.5 
 Received Vitamin A (≥1 dose) 319
‡
 30.1 
Maternal characteristics  
Median maternal age at delivery (IQR) - years 325 29.4 (24.4-34.2) 
Education ≥ any secondary school 324 50 
Median pregnancy CD4 closest to delivery (IQR) - cells/ul
3
  299 428 (293-578) 
 <200 cells/ul  299 10.4 
 200-349 cells/ul 299 24.7 
 350+ cells/ul 299 64.9 
On HAART during pregnancy 312 25 
NOTES: * N identifies the total number of participants with available information for each 
characteristic.
‡
Total number of children eligible to receive vaccine per GHESKIO vaccine schedule. 
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Size at birth 
Birth weight data were available for 280 infants in the GHESKIO sample.  Mean birth weight was 
2.99 ± 0.50 kg. Prevalence of LBW was 14.6%. In multivariable models with or without preterm 
delivery as a covariate, participation in the 5207 study, completion of infant ARV prophylaxis, 
maternal CD4 <200 and receipt of BCG vaccine in the first 7 days of life were significantly 
associated (p <0.05 ) with birth weight (Table 3.2).   
Table 3.2  Generalized Linear Model for birth weight (BW)(kg) including all children with 
BW (n=237) and only children with available gestational age data (n=170)  
NOTES:
  1
Reference category    ‡p<0.05 
 
   
  
  
Multivariate Models 
 All children with BW (n=237)  With BW + gestational age (n=170)  
 B SE Sig B SE Sig 
Intercept 3.5600 0.1562 0.000
‡
 3.5916 0.1760 0.000
‡
 
Pre-term birth (<37 weeks) N/A -0.5113 0.1750 0.004
‡
 
Maternal CD4 nearest 
delivery 
      
 <200 cells/ μl -0.2900 0.1144 0.011
‡
 -0.3030 0.1382 0.028
‡
 
  200-349 cells/ μl -0.1070 0.0764 0.162 -0.1180 0.0937 0.206 
 > 350 cells/μl 
1
 
. . . . . . 
No HAART in pregnancy -0.0100 0.0851 0.941 -0.0002 0.1040 0.998 
Infant ARV prophylaxis, none 
or incomplete 
-0.1220 0.0755 0.107 -0.1110 0.0932 0.235 
No BCG in first 7days  -0.1990 0.0761 0.009
‡
 -0.2090 0.0924 0.024
‡
 
5207 protocol, not enrolled -0.3480 0.1162 0.003
‡
 -0.3780 0.1191 0.002
‡
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Postnatal growth 
Figure 3.2 describes the overall growth pattern of GHESKIO children from 0-23 months.  At 
month 0 (0-15 days post-delivery) mean WAZ was low (-0.73 ± 1.27 SD) and mean LAZ very low 
(-1.31± 1.67 SD) compared to the WHO 2006 Growth Standard (Table 3.3). Forty percent of 
infants were stunted (LAZ<-2 SD) (Table 3.4).  Infants were proportionally sized at birth with 
mean WLZ above than the WHO Growth Standard Median (WLZ at month 0 = 0.21 ± 1.27 SD). 
 
Figure 3.2   Unadjusted mean z-score by age category for HIV-exposed uninfected GHESKIO                          
children.  Number of children included ranges from 71 to 161 per age category. 
  
-1.5
-1
-0.5
0
0.5
1
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
M
e
a
n
 z
-s
c
o
r
e Age (months)
WAZ GHESKIO
LAZ GHESKIO
WLZ GHESKIO
98 
 
Table 3.3 Mean z-scores (WAZ, LAZ, WLZ) at 0, 6, 9, 12, 18, 23 months in GHESKIO children 
compared to national Haitian data from DHS 2005-6 
  WAZ LAZ WLZ 
  N Mean ± SD p-value N Mean ± SD p-value N Mean ± SD p-value 
0 mo 
GHESKIO 91 -0.73 ± 1.27 
0.061 
85 -1.31 ± 1.66 
0.047
‡
 
75 0.21 ± 1.47 
0.78 
DHS 2005-6 22 -0.13 ± 1.51                                                          -0.52 ± 1.45 22 0.10 ± 1.94 
6 mo 
GHESKIO 130 -0.35 ± 1.19 
0.66 
123 -0.56 ± 1.41 
0.80 
124 0.13 ± 1.33 
0.35 
DHS 2005-6 56 -0.44 ± 1.39 56 -0.50 ± 1.24 56 -0.08 ± 1.57 
9 mo 
GHESKIO 161 -0.75 ± 1.43 
0.10 
157 -0.66 ± 1.46 
0.11 
158 -0.42 ± 1.26 
0.38 
DHS 2005-6 48 -0.37 ± 1.24 48 -0.29 ± 1.22 48 -0.23 ± 1.41 
12 mo 
GHESKIO 164 -0.65 ± 1.41 
0.22 
149 -0.76 ± 1.46 
0.11 
150 -0.29 ± 1.26 
0.36 
DHS 2005-6 50 -0.93 ± 1.37 50 -1.14 ± 1.35 50 -0.49 ± 1.46 
18 mo 
GHESKIO 140 -0.64 ± 1.30 
0.005
‡
 
134 -0.96 ± 1.34 
0.006
‡
 
133 -0.28 ± 1.21 
0.064 
DHS 2005-6 54 -1.25 ± 1.36 54 -1.58 ± 1.50 54 -0.66 ± 1.35 
23 mo 
GHESKIO 99 -0.75 ± 1.22 
0.066 
87 -1.13 ± 1.26 
0.000
‡
 
87 -0.20 ± 1.17 
0.73 
DHS 2005-6 44 -1.15 ± 1.12 44 -2.07 ± 1.02 44 -0.13 ± 1.25 
NOTES:
 ‡
p<0.05 
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Table 3.4 Prevalence of growth faltering (%WAZ<-2SD, %LAZ<-2SD, %WLZ<-2SD) at 0, 6, 9, 
12, 18, 23 months in GHESKIO children compared to national Haitian data from 
DHS 2005-6 
 Underweight    
%  WAZ <-2 SD 
Stunting                     
%  LAZ <-2 SD 
Wasting                       
% WLZ <-2 SD 
  N % p-value N % p-value N % p-value 
0 mo 
GHESKIO 91 15.4 0.84 85 40.0 0.006
‡
 75 6.7 0.70 
DHS 2005-6 22 13.6 22 9.1 22 9.1 
6 mo 
GHESKIO 130 9.2 0.18 123 13.0 0.25 124 8.1 0.35 
DHS 2005-6 56 16.1 56 7.1 56 12.5 
9 mo 
GHESKIO 161 19.9 0.026
‡
 157 16.6 0.029
‡
 158 8.9 0.57 
DHS 2005-6 48 6.3 48 4.2 48 6.3 
12 mo 
GHESKIO 164 17.1 0.64 149 20.1 0.78 150 8.0 0.21 
DHS 2005-6 50 20.0 50 22.0 50 14.0 
18 mo 
GHESKIO 140 15.7 0.10 134 19.4 0.005
‡
 133 8.3 0.092 
DHS 2005-6 54 25.9 54 38.9 54 16.7 
23 mo 
GHESKIO 99 12.1 0.34 87 21.8 0.000
‡
 87 8.0 0.53 
DHS 2005-6 44 18.2 44 59.1 44 11.4 
NOTES:  ‡p<0.05 
Mean WAZ improved steadily by 0.38 SD over the first 6 months of life then declined by 0.40 SD 
between 6 to 9 months after which it improved slightly.  LAZ increased by 0.81 SD by age 7 
months then declined by 0.63 SD across the 7-23 month period. Mean WLZ remained above -
0.50 SD across the first 23 months of life (Figure 3.2). 
Mixed-effects models with random intercepts and random slopes were fit for each outcome 
(WAZ, LAZ WLZ) using all available data from 0-23 months of age.  The models included the 
fixed effects of age at visit and the interaction between age at visit and period (0-6 months vs. 
7-23 months). The interaction term was significant for LAZ (p=0.000) and WAZ (p=0.000). 
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Therefore in subsequent analyses, the 0-6 month (Table 3.5) and 7-23 month (Table 3.6) 
periods were modeled independently.     
Table 3.5 Mutilevel models for change predicting 0-6 month growth outcome (WAZ, LAZ,                              
WLZ) at time of visit  
Variable 
 
Growth Outcome  
 
WAZ  LAZ WLZ 
ß SE p-value ß SE p-value ß SE p-value 
Intercept -4.9321 0.5573 0.000
‡
 -5.5832 0.6694 0.000
‡
 -0.1326 0.7690 0.863 
Infant age 0.0211 0.0234 0.37 0.0668 0.0290 0.023
‡
 0.1857 0.0823 0.025
‡
 
Infant age*Infant 
age 
            -0.0335 0.0121 0.006
‡
 
Infant, female 
gender 
      0.5360 0.1802 0.004
‡
       
Maternal education 
< secondary 
            -0.4061 0.2010 0.046
‡
 
Birthweight 
(continuous) 
1.4870 0.1441 0.000
‡
 1.5080 0.1757 0.000
‡
       
Maternal CD4 
closest to delivery 
                  
     <200 cells/ μl 
0.1938 0.3028 0.52       -0.7071 0.3988 0.079 
      200-349 cells/ μl 
-0.1746 0.2082 0.40       0.0268 0.2841 0.925 
     > 350 cells/μl 
1
 . . . 
      
. . . 
Not on HAART in 0-
24 mo 
0.2248 0.2143 0.30       0.2540 0.2815 0.369 
Infant perinatal ARV 
prophylaxis, not 
given or incomplete 
-0.4957 0.2036 0.017
‡
 -0.3558 0.2374 0.137       
No DPT3 -0.3753 0.1774 0.038
‡
 -0.4956 0.2081 0.019
‡
       
PMTCT, not enrolled             -1.3821 1.1547 0.234 
5207 protocol, not 
enrolled 
-0.0307 0.2401 0.90 -0.0468 0.2820 0.869 -0.0717 0.3182 0.822 
NOTES:   Gray shading indicates that variable was not significant predictor (p<0.1) of outcome in single 
variable analysis and therefore not included in the multivariable model.  Maternal age at delivery was 
not a significant predictor for any outcome in single variable models.   
1
Reference category    ‡p < 0.05 
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Table 3.6 Mutilevel models for change predicting 7-23 month growth outcome (WAZ, LAZ, 
WLZ) at time of visit 
Growth Outcome  
 
 
Variable 
WAZ LAZ WLZ 
ß SE 
p-
value 
ß SE 
p-
value 
ß SE 
p-
value 
Intercept -3.3301 0.6687 0.000
‡
 -2.6240 0.6894 .000
‡
 -1.8542 0.6043 0.002
‡
 
Infant age -0.0353 0.0163 0.030
‡
 -0.1576 0.0224 .000
‡
 -0.0242 0.0232 0.296 
Infant age*Infant age 0.0011 0.0005 0.032
‡
 0.0039 0.0007 .000
‡
 0.0012 0.0007 0.101 
Maternal education < 
secondary 
-0.5674 0.1474 0.000
‡
 -0.5184 0.1642 .002
‡
 -0.3487 0.1313 0.008
‡
 
Birthweight 
(continuous) 
1.2172 0.1595 0.000
‡
 1.3007 0.1727 .000
‡
 0.6886 0.1400 0.000
‡
 
Maternal CD4 closest 
to delivery 
                  
    <200 cells/ul -0.0225 0.2915 0.938       0.1726 0.2650 0.516 
     200-349 cells/ul 0.0262 0.1954 0.894       0.1666 0.1776 0.349 
     > 350 cells/μl 
1
 
. . . 
      
. . . 
Not on HAART in 0-24 
mo 
0.2472 0.2080 0.236       0.3027 0.1901 0.113 
Infant perinatal ARV 
prophylaxis, not given 
or incomplete 
-0.1328 0.1956 0.498 -0.3743 0.2154 .084       
No measles vaccine -0.3413 0.1780 0.057 -0.4939 0.1982 .013
‡
       
5207 protocol, not 
enrolled 
-0.5881 0.2976 0.050 -0.3500 0.3241 .281 -0.5807 0.2658 0.030
‡
 
NOTES:  Gray shading indicates that variable was not significant predictor (p<0.1) of outcome in single 
variable analysis and therefore not included in the multivariable model.  Infant sex, maternal age at 
delivery, receiving PMTCT services at GHESKIO were not significant predictors for any outcome in single 
variable models.    
1
Reference category.   ‡p < 0.05 
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Demographic variables. Mother’s education level was associated with all three outcomes from 
7-23 months but only WLZ from 0-6 months. Female gender was associated with improved LAZ 
outcomes from 0-6 months of age.   
In utero environment variables.  Birth weight was strongly associated with all growth outcomes 
in 0 to 6 and 7 to 23 month periods except WLZ in the 0 to 6 month model.  Neither low 
maternal CD4 nor HAART were significant in multivariable models for any of the 3 outcomes in 
either period.   
Access to care variables. Infant completion of the ARV prophylaxis regimen was associated with 
improved WAZ from 0-6 months.  Receiving the vaccine scheduled for the period being 
modeled (DPT3 at 6 weeks for 0-6 month, measles at 12 months for 7-24 months) was 
associated with improved LAZ and WAZ outcomes but not WLZ.  Participation in 5207 was 
associated with WAZ and WLZ outcomes in late infancy but no outcomes during the 0-6 month 
period.   
Comparison to DHS data  
The 2005-2006 Haiti DHS dataset included cross-sectional growth outcomes on 1190 children 
aged 0-23 months.  The smaller sample size in each age category is reflected in the higher 
standard deviations around estimates for the DHS children compared to GHESKIO (Table 3.3).   
  
 Figure 3.3a-c Unadjusted mean a) 
GHESKIO children compared to nationally representative sample from Haiti 
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WAZ b) LAZ and c) WLZ by age for HIV-exposed uninfected 
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At month 0, GHESKIO infants were significantly shorter (difference in LAZ = -0.83 p=.047) 
(Figure 3.3 and Table 3.3) and had a higher prevalence of stunting compared to the Haiti DHS 
group (LAZ< -2 SD 40.0% vs 9.1%  p=0.006) (Table 3.4).  Mean WAZ was 0.60 z -score lower in 
the GHESKIO children at month 0 but this difference was not statistically significant (Table 3.3).  
The GHESKIO population improved in WAZ and LAZ over the first half of infancy (see above) 
while mean WAZ and LAZ decreased from 0 to 6 months in 2005-6 Haiti DHS.  At 6 months of 
age there was no difference in mean z-score for any of the growth outcomes (Tables 3.3 and 
3.4).  Both populations demonstrated declining WAZ and LAZ scores over the 7-23 month 
period.  However, by 23 months, growth outcomes were strikingly better in the GHESKIO 
population (mean LAZ -1.13± 1.26SD, mean WAZ = -0.75± 1.22 SD) compared to the DHS (mean 
LAZ -2.07 ± 1.02 SD, mean WAZ = -1.15 ± 1.12 SD, LAZ p= 0.000, WAZ p=0.066).  There was no 
difference in mean WLZ or prevalence of wasting (WLZ<-2 SD) between the two groups at any 
age (Table 3.3 and 3.4).   
DISCUSSION  
Growth patterns of HIV-exposed uninfected children at GHESKIO were distinctive in three ways: 
1) infants were born at very low LAZ and WAZ but normal WLZ, 2) WAZ and LAZ improved 
across the first 6 months of life, and 3) the decline in z-scores from 7-23 months was not as 
dramatic as seen in similarly impoverished populations [12].  Each of these findings is discussed 
in sequence.   
Size at birth:   LBW prevalence in the GHESKIO population (14.6%) was slightly higher than the 
7-9% reported in HAART-naïve, HIV-exposed uninfected PMTCT cohorts from the early 2000s 
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[20]. It was not possible to assess preterm rates in the GHESKIO population but it was likely 
similar to the 25-42% reported in HAART-naïve, PTMCT populations in Sub-Saharan Africa [18, 
19] given that maternal HAART treatment has been associated with increased rates of LBW and 
preterm [35].  Mothers receiving HAART for longer duration (e.g. starting pre-conception) are at 
higher risk of preterm and LBW than those starting later in pregnancy [36].  
Such high rates of LBW and preterm suggest an in utero environment that is not favorable to 
fetal development.  The association between LBW and advanced maternal HIV disease during 
pregnancy (CD4<200) in the GHESKIO infants was consistent with other HIV-exposed 
populations [17-19].  However the mechanism by which in utero exposure to HIV virus and/or 
HAART contribute to LBW and/or preterm is not well understood.  
The most striking feature of the GHESKIO infants’ birth size is that the infants were extremely 
short but proportional in WLZ, suggesting that it is a high prevalence of stunting (40%) rather 
than wasting that is driving the LBW.  Although there is often concern about measurement 
error in length measurements on newborn infants [37], the steady gain in LAZ  across 0-6 
month period seen in the GHESKIO infants (as opposed to a more abrupt increase between 0-1 
or 2 months) increases confidence in the precision of our measurements.  Investigators in 
Zambia reported a similarly low LAZ at birth in HIV-exposed uninfected infants who received 
PMTCT intervention with ARV prophylaxis but no maternal HAART [20]. 
Improved birth weight outcomes associated with participation in 5207 trial and receiving BCG in 
the first 7 days of life likely reflect the effects of higher quality medical care during pregnancy 
and around delivery. 
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0-6 month period:  WAZ and LAZ scores in the GHESKIO population improved dramatically and 
unexpectedly over the first six months of life.  HIV-exposed uninfected PMTCT study 
participants in Zambia [20] and South Africa [18] also demonstrated improving LAZ across early 
infancy.  This pattern of improving LAZ is noteworthy given that GHESKIO infants are 
proportionally sized at birth.  Studies in IUGR populations consistently show that proportionally 
small-for-gestational age infants do not demonstrate catch-up growth while infants with low 
ponderal index do [38, 39].  With the assumed high prevalence of preterm in the GHESKIO 
population, the pattern may be at least partly attributed to accelerated postnatal growth rates 
observed in more mature preterm infants (gestational age>29 weeks ) [40].   
The period of improving WAZ and LAZ scores in the GHESKIO population corresponded to the 
period when infant formula was provided to the majority of HIV-exposed infants at no cost.  
Data from higher-resource contexts show that growth patterns for artificially fed infants 
generally diverge from those of breastfed infants around 3 months of age with artificially fed 
children gaining up to 600-650 g more from 4-12 months than breastfed infants [41]. However 
differences in length gain are not usually as pronounced between feeding approaches [41].  This 
study did not include measures of morbidity including diarrhea – a major contributor to growth 
faltering in low income populations [42] and very common in children who are artificially fed 
[43]. The catch-up growth we observed in these formula-fed infants occurred in spite of 
diarrhea risks.  
A possible explanation for this is that GHESKIO children were all receiving cotrimoxazole 
prophylaxis during early infancy [8, 44-48] – some children received the antibiotic daily for 
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more than 12 months before their HIV-status was confirmed.  While cotrimoxazole has been 
shown to reduce morbidity risk in HIV-infected infants [49], it is not known whether 
cotrimoxazole would protect HIV-exposed uninfected infants against the morbidity-related 
growth deficits we might expect in a population exposed to artificial feeding and poor hygienic 
conditions. Further research on the potential growth-promoting effects of cotrimoxazole is 
needed. 
It is plausible that differences in fetal and early postnatal growth patterns can be attributed 
more directly to in utero exposure to HIV infection and/or HAART.  As mentioned previously, 
there is evidence for increased risk of preterm and LBW with or without HAART exposure 
during pregnancy.  There is also evidence for altered postnatal immune system function in HIV-
exposed uninfected infants with and without in utero exposure to HAART [50-52].  Changes in 
immune function may contribute to growth outcomes as alterations in pro-inflammatory 
cytokine proliferation can either restrict or accelerate bone formation in young children [53].  
This presents a potential biological pathway for altered in utero and early postnatal growth in 
HIV-exposed uninfected infants compared to unexposed infants. 
7-23 month period:  Growth indicators of GHESKIO infants declined from 7-23 months, the 
period during which nutrition support was no longer provided by the clinic.  However, this 
decline was not dramatic when compared to the decreased in LAZ described by Victora et al 
[12] when they applied the WHO 2006 Growth Standard to pooled results from nationally 
representative cross-sectional anthropometric surveys from in 54 low and middle income 
countries. Mean LAZ at age 24 months in the Victora et al analysis was below -1.75 SD [12].  
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Mean WAZ at 24 months for the GHESKIO children was above -1 SD and mean LAZ was just 
below -1 SD suggesting that many GHESKIO children were within the normal range on the WHO 
2006 Growth Standard.   
Comparison to the DHS:  Our findings suggest that HIV-exposed uninfected infants at GHESKIO 
did not follow the same growth pattern as their unexposed peers in the general Haitian 
population.  Although they were born at much lower LAZ, HIV-exposed uninfected infants at 
GHESKIO reached the same mean WAZ and LAZ as the general Haitian population by six months 
of age.  The GHSEKIO children had better growth outcomes in the 7-23 month period compared 
to the DHS population.  Marazzi et al [54] reported a similar finding in PMTCT cohorts in Malawi 
and Mozambique.  With the dramatic scale-up of PTMCT and other interventions targeted 
specifically to HIV-affected populations in low-income populations, it is likely that HIV-exposed 
infants are receiving better medical care and support than the general population.  This 
improved-access-to-care hypothesis is supported by findings within the GHESKIO cohort.   
Improved growth outcomes in each age period (birth, 0-6 and 7-23) were associated with 
receiving the age-appropriate vaccine for that period.    Participation in the 5207 protocol 
predicted improved growth outcomes from 7-24 months but not 0-6 months. The majority of 
GHESKIO infants received no-cost infant formula from 0-6 months but only 5207 protocol 
participants continued receiving infant formula during the 7-12 month period.  
Maternal education level also predicted of growth in GHESKIO infants from 7-24 months but 
not 0-6.  Assuming that higher education level reflects higher socioeconomic status and 
somewhat greater capacity to utilize available resources effectively, these characteristics may 
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have been more important during the period when most infants no longer received infant 
formula and caregivers had to access an adequate food supply on their own.   
Limitations:  Some limitations in our medical chart review study design and analysis approach 
must be taken in consideration when interpreting our findings.   In particular, the lack of data 
on gestational age, infant feeding practices and morbidity as well as maternal height and 
economic status limit interpretation of multivariate models.  Subjects from the DHS data were 
the most feasible comparison group available for a policy-relevant analysis but an adequately 
sized sample of unexposed children from the same urban/peri-urban Haitian environment 
would provide stronger verification of the the observed differences in growth patterns between 
GHESKIO infants and their urban peers.   
CONCLUSIONS 
In the current era of advancing PMTCT interventions and HAART, findings from this descriptive 
comparative study highlight the need for studies that are designed to examine in utero 
development and subsequent growth across the first two years of life.  Findings of improved 
outcomes in HIV-exposed infants in later infancy compared to the general population raise 
important policy-related questions about equity in targeting services to HIV-exposed children 
when the general population is also at risk of poor health outcomes.   
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CHAPTER 4 
DOES PARTICPATION IN AN INFANT FEEDING SUPPORT STRATEGY FROM 6-12 MONTHS OF 
AGE IMPROVE GROWTH OUTCOMES AMONG HIV-EXPOSED INFANTS IN URBAN HAITI? 
ABSTRACT  
Nutrition support for non-breastfed babies of HIV-infected mothers is a recognized need, 
however there is a weak evidence base for effective programmatic solutions.  The objective of 
our study was to implement and evaluate a new Infant Feeding Support Strategy (IFSS) for HIV-
exposed infants 6-12 months of age attending the GHESKIO pediatric clinic.  We compared 
growth outcomes in IFSS participants (n=73) at baseline, end of intervention and 6-months post 
intervention to a historical control group of same-age HIV-exposed uninfected infants seen at 
GHESKIO in the year before the intervention (n=294).  The plausibility of attributing growth 
differences to participation in the intervention was assessed using multiple approaches.  
The intervention and historical control groups did not differ significantly at baseline except that 
the intervention group had a lower proportion of children who had completed short-course 
perinatal ARV prophylaxis.  At the end of the intervention period, the intervention group had a 
significantly lower prevalence of underweight (WAZ<-2 SD, 6.8%) and stunting (LAZ<-2 SD, 
9.6%) than the historical control group (WAZ<-2 SD, 20.8%, p=0.007; LAZ<-2 SD, 21.2%, 
p=0.029).  Wasting was lower in the intervention group (WLZ<-2 SD, 2.9%) than the historical 
control (WLZ<-2 SD, 8.9%) but the difference was not statistically significant. There were no 
differences between groups in mean WAZ, LAZ, WLZ at any time during the intervention or 
post-intervention period, nor in the prevalence of growth faltering between groups 6-months 
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post intervention.   The additional analyses supports the conclusion that improvements in 
growth outcomes can be attributed to participation in the IFSS.  The IFSS is a promising program 
model that can be adapted and scaled-up to other HIV-care contexts.   
INTRODUCTION 
The need for better nutrition during infancy to improve growth and child survival outcomes is 
well recognized [1-5] and is especially acute in the context of maternal human 
immunodeficiency virus (HIV) infection.   WHO Guidelines on Infant Feeding and HIV call for 
support of HIV-infected caregivers during infant feeding transitions across the first year of life 
[6].   
In 2007, more than 85% of HIV-exposed infants at the GHESKIO centers in Port-au-Prince, Haiti, 
were replacement-fed from birth [7]. The clinic provided a six-month supply of no-cost infant 
formula to HIV-infected caregivers who chose to replacement feed and were enrolled in the 
Prevention of Mother to Child Transmission (PMTCT) program.   A review of pediatric clinic 
medical records showed that risk of growth faltering  in HIV-exposed uninfected infants 
increased from age 6 months onwards [8].  No infant feeding support existed at GHESKIO for 
infants for this age group.    
Growth faltering is common globally, and food supplementation combined with behavior 
change education about infant and young child feeding (IYCF) practices is a recommended 
approach for reducing the risk of stunting and the burden of disease in children 6-24 months of 
age [9, 10].  The impact of IYCF interventions depends on the baseline health and nutritional 
status of the target population, timing of initiation and duration of intervention as well as a 
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range of other factors related to context, quality of program design and  program delivery [11-
13]. In addition to increasing the nutrient  quality of the infant’s diet, effective complementary 
feeding interventions promote responsive feeding practices and promote food safety and 
hygiene [11, 12]. 
The objective of our study was to implement and evaluate a new infant feeding support 
strategy (IFSS) at GHESKIO targeting HIV-exposed non-breastfed infants between 6-12 months 
of age.  The evaluation had three aims: 1) to estimate the magnitude of effect on growth 
associated with participation in the IFSS 2) to determine whether growth effects were sustained 
6 months post-intervention, and 3) to examine the plausibility of attributing the observed 
growth effects to participation in the intervention [14].  
Due to ethical concerns and logistical constraints, it was not feasible to randomize treatment or 
follow a concurrent control group.   For Aims 1 and 2 we compared growth outcomes in 
intervention participants to children of the same age who were seen at GHESKIO in the year 
prior to the intervention (referred to as the historical control).  Available outcomes for the 
historical control were limited to data collected in routine clinic visits. For Aim 3, we examined 
indicators of comparability between groups, intervention utilization and a number of pre-post 
intermediate outcomes within the intervention group. 
SUBJECTS AND METHODS 
Study population. The intervention study was conducted from July 2008 to February 2010 at the 
GHESKIO Centers, a Haitian NGO dedicated to clinical care, research and training in HIV/AIDS 
and related infectious diseases.   GHESKIO provides free medical care to HIV-affected clients 
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from across the Port-au-Prince metro region, most of whom are poor.  The study clinic is 
located immediately adjacent to some of the city’s largest slum communities.   
GHESKIO provided pediatric clinical care to all HIV-exposed children for the first 23 months of 
life.  All HIV-exposed infants received cotrimoxazole prophylaxis from their first clinic visit until 
negative HIV status was confirmed. Pediatric HAART was provided to all confirmed HIV-infected 
infants. HIV-infected women who received prenatal care at GHESKIO as part of the PMTCT 
program were given perinatal ARV prophylaxis per Ministry of Health and Population guidelines 
and counseled about options for feeding during early infancy.  At the time of this study, 85-90% 
of all HIV-exposed infants at GHESKIO were replacement fed from birth [7].  
HIV-exposed children age 5.5-6.5 months without severe malnutrition (WLZ > -3 SD) and no 
known allergy to peanuts who visited the pediatric clinic between 15 June 2008 and 5 January 
2009 were eligible for recruitment into the intervention group.  Potential participants were 
identified by pediatric clinic staff from the daily clinic visit registry.  Infants were screened for 
enrollment based on birth date and maternal HIV test result as recorded in the GHESKIO 
enrollment database. Oral and written informed consent was obtained from caregivers of all 
infants prior to study enrollment.  
The historical control group used medical records from all HIV-exposed uninfected children age 
5.5-19.0 months who were born between 1 November 2005 and 15 December 2006, had a least 
one clinic visit after July 2007 and were not enrolled in a small pediatric study protocol 
conducted at GHESKIO during part of that period.  
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The study was approved by the GHESKIO Centers Institutional Review Board in Port au Prince, 
Haiti, the Cornell University Committee on Human Subjects in Ithaca, NY and the Weil-Cornell 
Medical College Institutional Review Board in New York, NY.   
Study design. This was a quasi-experimental study of the effectiveness of a 24-week 
intervention for the prevention of growth faltering in HIV-exposed children.  The IFSS was 
designed to increase infant nutrient intake through provision of a fortified-food supplement. 
Behavior change education about IYCF, hygiene and diarrhea treatment was a secondary 
pathway to improve overall dietary nutrient intake and decrease nutrient losses due to 
diarrheal illness (Figure 1). The evaluation was not designed to distinguish the relative 
contribution of the supplement versus the behavior change education components to growth 
outcomes.  
  
 FIGURE 4.1  The postulated pathway between 
improved growth outcomes among intervention participants.   
relative contribution of the activity to improved growth outcome compared to the other intervention 
activities.   Figure legend: Infant and Young 
caregiver (CG)   
 
Intervention. The IFSS included 3 
supplement that provided 50% of daily energy needs and 
key micronutrients for the target age group
or individualized counseling sessions 
including immunizations, high-dose vitamin A
solution and household food rations.  
the established schedule.   
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Child Feeding (IYCF), Fortified Manba supplement 
activities 1) provision of a daily ration of lipid-based 
the RDA or Adequate Intake 
 2) IYCF education delivered through
and 3) promotion of underutilized clinical services 
 supplementation, chlorine water 
Participants continued pediatric clinical visits 
 
(FM), 
(AI) of 
 biweekly group 
purification 
according to 
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Caregivers and infants came to the clinic every two weeks across the 24-week intervention 
period.  Children were enrolled in the intervention at age 5.5-6.5 months and were 11.0-12.35 
months of age at intervention end.  All participants were assigned to a “caregiver club” that 
included 8-12 infants born within 4 weeks of one another and their caregivers.  Children were 
followed for 26 weeks post-intervention with visits scheduled every 4 weeks for data collection 
purposes only.   
A team of two IFSS counselors and two study assistants delivered all intervention activities at 
the GHESKIO site.  Each visit included a brief interview about illness and supplement use since 
last visit, IYCF education, and distribution of supplement. For the education component, visits 
alternated between one-on-one visits with a study counselor for growth monitoring and 
individualized counseling and “caregiver club” visits for interactive group-based IYCF education. 
To help ensure delivery of the supplement, missed visits were followed up by study staff 
through phone calls and/or home visits as feasible.  Educational messages from missed group 
lessons were reviewed in subsequent individual visits.    
Education sessions. Topics for individual counseling and group education were based on key 
practices identified in the WHO Guiding Principles for Feeding non-Breastfed Children from 6-
24 months of age [15].  Based on formative interviews with HIV-infected mothers of children in 
the targeted age range, we developed context-specific messages about food choice, quantity 
and frequency of feeding, responsive feeding behaviors, hygiene, and diarrhea care. Each 45-60 
minute caregiver club session was delivered by a staff counselor who followed a structured 
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curriculum outlined in Table 4.1. Messages from club sessions were reinforced during the 
individual visits.   
TABLE 4.1 Topics for caregiver club IYCF education by intervention week and age 
VISIT APPROXIMATE 
INFANT AGE 
(MONTHS) 
TOPIC 
Week 0 6 How to use Fortified Manba supplement 
Week 4 7 Hygiene and prevention and treatment of diarrhea 
Week 8 8 Learning to eat: feeding children before 12 months 
Week 12 9 Quantity and quality of food for children 9-12 months 
Week 16 10 Responsive feeding 
Week 20 11 Feeding children after 12 months of age 
 
Supplementary food.  Given that this was a non-breastfeeding population with limited access to 
breast milk replacements, we aimed to have the daily supplement ration provide about 50% of 
daily energy needs, approximating the usual energy intake from breast milk in fully breastfed 
children in this age group [12, 15].  Other criteria for the supplement were that it be 
developmentally appropriate for the infants’ motor skills and small gastric capacity, required 
minimal cooking and preparation time, met food safety standards, was locally produced and 
was acceptable to the population.   
The lipid-based nutrient supplement (LNS) used in the study was produced by Meds and Foods 
for Kids (Cap Haitien, Haiti). The ingredient composition by weight was 25% peanuts, 30% milk 
powder, 28% sugar, 15% oil, and 14% micronutrient pre-mix. The targeted daily ration of 65g 
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(approximately 4 tablespoons) provided 345 kcal and an RDA/AI of problem micronutrients for 
children age 6-12 months (Table 4.2).   
TABLE 4.2 Energy and micronutrient content of the supplement 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES: 
1
 Dietary Reference Intakes from the Institute of Medicine, National Academies. Energy and 
protein intakes are RDA.  All other values are Adequate Intakes. 
2
 Zinc fortification levels were based on 
recommendations from the International Zinc Nutrition Consultative Group http://www.izincg.org/ 
 
The supplement was packaged in plastic 500-gram containers with screw caps.  Each caregiver 
was given two jars per biweekly visit and a separate small glass jar for measuring purposes.  
Caregivers returned containers with any unused supplement at the following visit. 
Key supplement feeding messages were to mix the supplement into first portion of porridge or 
other soft food or to feed directly from a spoon as a snack.  A one-week, home-based pilot trial 
Nutrient 
Per 
100g 
Per 65g 
ration Units 
DRI
1  
              
6-8 mo 
DRI
1
                
9-11mo 
 
Energy 
 
529 
 
344 
 
kcal 769 858 
Protein 15.9 10.3 g 11 11 
Fat 33.5 21.8 g 30 30 
Calcium 415 270 mg 260 260 
Iron 17 11 mg 11 11 
Zinc 7.7 5.0
2
 mg 3 3 
Iodine 200 130 mcg 130 130 
Folate 123 80 DFE 80 80 
Vitamin A 693 500 mcg RAE 500 500 
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of supplement use conducted prior to the intervention launch confirmed that the supplement 
and delivery approach were acceptable to caregivers and infants in the target age group.  
Measurement of outcomes. The primary outcomes were mean weight-for-age, length-for-age, 
and weight-for-length after 24 weeks of intervention.  These were analyzed as both mean z-
scores based on the WHO 2006 Growth Standard and prevalence of underweight (% of children 
with WAZ <-2 SD below median), stunting (% of children with LAZ <-2 SD below median), and 
wasting (% of children with WLZ <-2 SD below median).    
Length and weight of intervention participants were measured every 4 weeks.  Length was 
measured in the recumbent position using an infantometer (Easy-Glide Bearing Infantometer, 
Perspective Enterprises, Portage, MI) to the nearest 0.1 cm and weight was measured on a 
research-quality digital scale (Tanita Model 1583, Tokyo, Japan) to 0.01kg. Clinic staff received 
routine refresher training on anthropometric measurement techniques.  Growth data for the 
historical control group was collected using the same equipment and staff protocols as the 
intervention period.  Due to the use of medical record data there was variability in number and 
timing of visits available per child in the historical control. 
Supplement disappearance was assessed every 2 weeks in the intervention group by weighing 
all jars delivered to and returned by caregivers.   Caregivers were asked directly about 
supplement consumption by the child since the previous distribution.  Supplement use was also 
assessed using 24-hour dietary recalls at weeks 12, and 24. Attendance at all visits was 
documented including portion of club session attended. 
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Data on diarrheal morbidity were collected by the study counselor at each visit.  Caregivers 
were asked whether child had diarrhea in the previous 7 days. Follow-up questions included 
duration of illness, frequency of watery stools, and any treatment by the caregiver. A diarrhea 
episode was defined as 3 or more loose stools in a single day.    
IYCF, hygiene and diarrhea-related knowledge and practices were assessed in the intervention 
group using a survey at weeks 0 and 24.   
HIV status, immunization and vitamin A records, and a limited number of demographic 
variables were collected for all study children from their GHESKIO clinical records.  Additional 
data on socioeconomic status and access to GHESKIO services were collected in the 
intervention group using a survey.   
Sample size.  A sample size of 82 intervention group children was estimated to be sufficient to 
detect a 0.5 LAZ difference between the intervention and historical control groups with 95% 
sensitivity and 80% power.  This was calculated based on effect sizes observed in moderately 
malnourished Malawian children receiving a lower dosage of a similar LNS without education 
targeted to the mother [16]. Our sample size calculation assumed that 10% of the intervention 
children would not complete the 24-week intervention, 10% might be excluded due to HIV-
infection, and up to 25% might be excluded if the mother did not receive prenatal care at 
GHESKIO. 
Statistical Analysis. Data management was completed using Microsoft Access version 2000 and 
all statistical analyses were performed using SPSS software version 19 (Chicago, IL: SPSS Inc).  
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Growth z-scores were calculated based on the WHO 2006 Child Growth Standards using the 
WHO Anthro macro for SPSS (Geneva: WHO).  
To assess cross-sectional growth outcomes at intervention start (week 0), end of intervention 
(week 24) and six-months post intervention (week 50), mean WAZ, LAZ, and WLZ were 
compared between intervention and historical control group using a t test and prevalence of 
underweight, stunting, and wasting were compared by Pearon’s Chi-square or Fisher’s Exact 
test. Multilevel models for change controlling for group and child age at visit were used to test 
for a treatment effect on the slopes of growth trajectories across the 0-24 week and 24-50 
week periods. The SPSS 19 MIXED procedure with random intercept and random slopes 
accounts for repeated measures on individuals and allows for irregularly spaced 
measurements
 
and missing values across individuals.  The adjusted models included infant birth 
weight and maternal education as covariates.  
For all other variables, means were assessed by t test and categorical variables by Pearon’s Chi-
square or Fisher’s Exact test.  Statistical significance was accepted at a 0.05 level and all tests 
were two-sided.   
RESULTS 
Eighty-two children were enrolled in the intervention group (Figure 4.2).  One HIV-infected child 
was excluded from analysis due to the known association between HIV infection and poor 
growth.   Seventy-three HIV-negative infants completed the intervention and were included in 
the analyses of 24-week outcomes.  The post-intervention follow-up period was interrupted by 
a highly destructive earthquake in January 2010.  Sixty-two HIV-negative children completed a 
127 
 
post-intervention follow up visit at approximately 50 weeks (17-18 months of age) and were 
included in analysis. There was a total of 294 HIV-negative children included in the historical 
control group contributing 944 observations between 5.5 and 12.5 months of age and 844 
observations between 12.5-19.0 months of age (Figure 4.2).   
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                                                                                                               HISTORICAL CONTROL GROUP 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.2   Flow chart detailing the inclusion of  children in analysis of growth outcomes at the end 
of intervention (week 24) and  six months post-intervention (week 50).   There was a total of N=294 
children in the historical control with medical record data on growth available to be a comparison group 
at appropriate age for end of intervention and/or post intervention.  LTF = lost-to-follow up . 
 
Intervention children included in 
analysis of end of intervention 
outcomes (age 11-12.25 mo) 
n= 73 
1 HIV-infected   
child excluded  
Children complete intervention  
n= 74 
4 deaths                              
3 drop outs                                      
2  LTF  
3  deaths                                    
8  LTF  
Intervention children included in 
analysis of the post intervention 
outcomes (age 17-18.75 mo) 
n= 62 
Children seen at GHESKIO in previous 
year with available growth data at 
age 11-12.25 mo  
n= 138 
Children seen at GHESKIO in 
previous year with available growth 
data at age 17-18.75 mo 
n= 219 
Children enrolled in intervention 
n= 82 
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The baseline characteristics of the intervention and historical control groups are presented in 
Table 4.3.  There were no differences between intervention and historical control groups in 
gender, proportion enrollment in the GHESKIO PMTCT program, BCG vaccine coverage or other 
maternal variables.   Although not statistically significant, mean birth weight was slightly lower 
and prevalence of low birth weight higher in the intervention group compared to historical 
control.  Fewer infants in the intervention group completed the perinatal ARV prophylaxis 
regimen compared to the historical control (p=0.016).   
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TABLE 4.3 Baseline characteristics of intervention and historical control children from GHESKIO 
clinic records 
 Characteristic 
Intervention Historical Control 
p-value 
N
1
 Statistic N
1
 Statistic 
Infant characteristics 
 
 Female gender (%) 73 49.3 294 49.0 0.96 
 PMTCT participant (%) 73 89.0 294 85.0 0.36 
xxx Mean  birth weight (kg) 62 2.82 ± 0.55 231 2.95 ± 0.49 0.073 
      Birth weight < 2500g  (%)  62 22.6 231 15.6 0.19 
 Completed short course ARV prophylaxis (%) 63 60.3 250 76.4 0.016
*
 
 Received BCG vaccine (%) 72 91.7 275 93.8 0.43 
 
Ever breastfed before age 6 mo (%) 73 12.3 
NA 
 
Still breastfed at age 6 mo (%) 73 0.0 
NA 
 
Received free Enfamil before age 6 mo (%) 73 90.4 
NA 
 
Started semi-solids before age 6 mo (%) 73 79.5 
NA 
Maternal characteristics 
 
 Education ≥ any secondary school (%) 67 50.7 269 50.6 0.98 
 On HAART during 0-24 month period (%) 64 37.5 258 31.8 0.38 
 
Employed in previous 12 months (%) 
73 30.1 NA 
Household characteristics 
 
Mean Household Asset Index
2
  73 10.15 ±2.58 
NA 
 
Has a water source in home (%) 73 49.3 
NA 
 
Has an improved latrine or toilet (%) 73 64.4 
NA 
NOTES: 
1
 Total number of children with available data in GHESKIO record for characteristic. Overall N= 73 in the 
intervention group; N= 294 in historical control. 
2
 Asset Index is measure of how many total assets owned by 
participant’s household out of a list of 16 items appropriate to the urban Haiti context.   * Statistically significant at 
p <.05 level, NA = Not available for historical control group 
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Impact on growth. In the cross-sectional analysis, there were no differences in mean z-scores 
between groups at any time across the intervention or post-intervention follow-up periods 
(Table 4.4).  
TABLE 4.4 Cross-sectional mean WAZ, LAZ, and WLZ at baseline (week 0), end of 
intervention (week 24) and 6-months post intervention (50 weeks)  
Anthropometric 
Outcome 
Baseline End of intervention 
6-months post 
intervention 
N Mean ± SD 
p-
value 
N Mean ± SD 
p-
value 
N Mean ± SD 
p-
value 
Weight-for-age 
(WAZ) 
I 73 -0.69 ± 1.09 
0.22 
73 -0.58 ± 0.97 
0.22 
62 -0.70 ± 1.07 
0.54 
HC 138 -0.49 ± 1.19 192 -0.77 ± 1.39 219 -0.60 ± 1.25 
Length-for-age 
(LAZ) 
I 73 -0.78 ± 1.31 
0.50 
73 -0.74 ± 1.20 
0.76 
61 -1.07 ± 1.16 
0.53 
HC 130 -0.64 ± 1.40 179 -0.79 ± 1.41 206 -0.95 ± 1.37 
Weight-for-length  
(WLZ) 
I 73 -0.16 ± 1.19 
0.34 
73 -0.28 ± 0.98 
0.31 
61 -0.29 ± 1.09 
0.84 
HC 131 0.01 ± 1.32 180 -0.43 ± 1.21 203 -0.25 ± 1.15 
NOTES: Age of intervention (I) and historical control (HC) children at 0 weeks was 5.5-6.76 months, 24 
weeks was 11.0-12.25 months, 50 weeks was 17.0-18.75  
 
Prevalence of all three indicators of growth faltering were slightly higher in the intervention 
group compared to historical control at week 0 (n.s) but thereafter growth faltering was much 
less prevalent in the intervention group.  At week 24, the prevalence of underweight was 67.3 
% lower (p=0.007) and stunting 54.7% lower (p=0.029) in the intervention compared to 
historical control. There was a 69.7% lower prevalence of wasting at 24 weeks in the 
intervention but this was not statistically significant (Figure 4.3).
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Figure 4.3      Prevalence of underweight (A), stunting (B) and wasting (C) in intervention                                                  
and historical control groups at baseline (week 0) and end of int
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In further analysis using multilevel models for change to describe growth trajectories from age 
6-12 months, there was a significant group*age treatment effect in the WAZ and LAZ 
unadjusted and adjusted models but not the WLZ models (Table 4.5).  This treatment effect is 
modeled for WAZ and LAZ in Figure 4.4.  Across the 6 to 12 month age period, anthropometric 
indicators improved slightly in the intervention group while they decreased dramatically in the 
control group.   
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Figure 4.4    (A) mean WAZ and (B) mean LAZ by age in months in intervention (- - - ) and 
historical control (        ) groups predicted using unadjusted multilevel models for change with 
random intercepts and slopes. p-value is reported for Group*Age interaction. * Statistically 
significant at p <.05 level  
p = 0.027* 
p < 0.001* 
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There was no difference in mean z-scores (Table 4.4) or prevalence of growth faltering between 
the intervention and the historical control groups six-months post intervention. Stunting 
prevalence was 20% and wasting was 7-8% in both groups.  The group*age term was not 
significant for WAZ, LAZ or WLZ models for the 24-50 month period (not shown) suggesting that 
growth effects were not sustained post intervention.   
Provision and utilization of intervention. There were no documented interruptions in provision 
of the intervention by the GHESKIO staff team.  Mean disappearance of supplement across the 
24-week intervention period was 97.0% ± 3.51 based on weighing of jars.  96.4% of participants 
used at least 90% of all supplement provided. There was good agreement between caregiver 
responses to direct questions about whether supplement was fed to the child in the previous 
day (80% at week 12, 73.6% at week 24) compared to supplement use in the previous day 
reported in the 24-hour recall (80.8% at week 12, 63.0% at week 24).   
Mean attendance on caregiver club visit days was 87.4% ± 15.7.    Using a stricter measure 
requiring the caregiver to be present for at least 50% of the club teaching time, average 
attendance rate at caregivers clubs was 73.3% ± 22.2.     
Participation in the intervention was associated with increased utilization of other clinical 
services.  97.3% of the intervention group received at least one dose of vitamin A compared to 
28.7% of the historical control. Within the intervention group, 95.9% reported ever receiving a 
household food ration from GHESKIO at week 24 compared to 52.1% at week 0. 
Caregiver knowledge. Overall, the percentage of caregivers who identified positive IYCF and 
hygiene practices increased from baseline (week 0) to end of intervention (week 24) (Table 4.6). 
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This confirms that new IYCF knowledge was received and understood by the participating 
caregivers.      
TABLE 4.6 Changes in caregiver knowledge related to IYCF, diarrhea treatment and hygiene 
practices from baseline (week 0) to end of intervention (week 24)  
  
Baseline 
 
End of 
intervention p- value 
 
N
1
 % response 
 
N
1
 % response 
How can you encourage a child who does not want to eat?      
 
 
Feed with patience  73 17.8 
 
72 
 
51.4 0.000* 
 
Talk to child  73 13.7 
 
72 
 
55.6 0.000* 
How can you treat diarrhea?        
 
 
Give ORS / home fluids  73 100 
 
72 
 
98.6 0.50 
 
Give child same or more food during 
diarrhea  
73 17.8 
 
72 
 
36.1 0.02* 
 
Give child more liquid during diarrhea 73 6.8 
 
72 
 
45.8 0.000* 
 
Give child an extra plate of food per day 
after diarrhea has finished 
3
 
72 76.4 
 
72 
 
95.8 
0.001*
2
 
How can you protect your child from germs?  
       
 
 
Wash hands  70 15.7 
 
72 
 
47.2 0.000* 
 
Put pants on child  70 7.1 
 
72 
 
23.6 0.007* 
 
Wash fruits and vegetables  70 1.4 
 
72 
 
16.7 0.001*
2
 
 
Treat water  70 4.3 
 
72 
 
8.3 0.49 
NOTES:  
1  
Total number of respondents for question.  
2
Analysis by Fischer’s Exact Test due to cell with 
count < 5.  
3
  Mothers were questioned directly about feeding after diarrhea ( e.g.  Should you feed an 
extra plate her day?) Responses to other questions were not individually prompted by interviewer. All 
responses given by a mother to the question were noted. * Statistically significant at p <.05 level 
Diarrheal morbidity. There was a high prevalence of diarrhea in the intervention group. Mean 
prevalence of diarrhea (at least 3 stools) in previous 7 days across the 24-week intervention 
period was 20.2% ± 15.4.  In our study, 69.9% of participating caregivers reported that the 
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infant had diarrhea in previous 7 days at 10% or more of their biweekly visits.  Cross-sectional 
prevalence of diarrhea in the previous 7 days declined in the intervention group from baseline 
(26.4%) to end of intervention (11.11%) (p=0.019)  (Figure 4.5).  Use of positive treatment 
practices among those with diarrhea, including use of oral rehydration solution (ORS) and 
increasing intake of liquids, increased across the intervention period while food-related positive 
behaviors declined.  Changes in treatment behaviors were not statistically significant, possibly 
due to the small total number of children with diarrhea at any single visit (Figure 4.5).  
Figure 4.5 Diarrhea prevalence and caregiver treatment behaviors at baseline (week 0), 
mid-intervention (week 12) and end of intervention (week 24).  Nine children had diarrhea at 6 
weeks, 12 at 12 weeks, and 8 at 24 weeks.  *Decrease in prevalence of diarrhea from week 0 to 
24 is statistically significant (p=0.019) 
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DISCUSSION  
HIV-exposed, replacement-fed GHESKIO infants who participated in the IFSS had lower rates of 
underweight and stunting at the end of the intervention period compared to HIV-exposed, 
replacement-fed children of the same age who were seen at GHESKIO during the year prior to 
the intervention.   The pattern of reduced prevalence of growth faltering without a difference 
between groups in mean growth z-scores has been shown previously [9].  It suggests that 
children who were smaller at enrollment (e.g. in the left tail end of the z-score distribution) had 
greater potential to benefit from the intervention than children who started the intervention at 
a higher z-score.   
Based on findings of a sustained post-intervention reduction in severe stunting among 
Malawian children of similar age who received LNS for 12 months [17], we hypothesized that 
exposure to the IFSS educational elements would contribute to sustained improvements in 
growth outcomes during the post-intervention period.   However, growth effects in our study 
were not sustained at 6-months post intervention.  Cross-sectional prevalence of growth 
faltering at week 50 was equally high in the intervention and historical control groups and 
suggests the need to extend the intervention period into the second year of life. This is 
consistent with data from populations across the developing world where children are at high 
risk of stunting until 24 months of age or beyond [18].  
Given the non-randomized design, to assess the plausibility of attributing the growth impact 
observed in our study at end of intervention to the IFSS rather than external factors, we needed 
to answer three questions [14, 19]: 1) Were the intervention and historical groups comparable 
at the age of enrollment?  2) Was the intervention actually delivered to and utilized by 
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participants? 3) Was the direction and magnitude of changes in intermediate outcomes along 
the causal pathway from intervention inputs to growth outcomes in the expected direction?     
Comparability at baseline.  Mean WAZ, LAZ, and WLZ were slightly lower in the intervention 
group at week 0 compared to the historical control and prevalence of growth faltering was 
slightly higher.  These differences were not statistically significant. Looking at available birth 
weight data, the intervention children had a slightly lower mean birth weight and higher rates 
of LBW than the historical control. This suggests that the differences in size and prevalence of 
growth faltering between the two groups were present since birth and not likely the result of 
postnatal divergence in the slope of their growth trajectories. 
Comparison of other available baseline characteristics in the two groups showed that the 
intervention and historical control groups were similar in all characteristics except completion 
of perinatal ARV prophylaxis regimen.  A previous study in the GHESKIO population showed no 
association between completion of ARV prophylaxis and growth in late infancy [20]. 
Delivery and utilization.  Overall delivery and utilization of the intervention was high.  Although 
it was not possible to measure supplement consumption by the individual children directly, 
measures of supplement disappearance using the weighing approach and caregivers’ reported 
feeding practices were consistent and suggest that overall supplement consumption was high. 
We did not explicitly question caregivers about the degree of sharing of the supplement with 
other children or adults in the household at each visit. Based on qualitative interviews 
conducted at the end of intervention, mothers who were questioned about sharing behaviors 
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generally reported that sharing was limited.  Mothers with fewer economic resources and 
larger family size were more likely to report sharing.   
Caregivers were present for about three-quarters of the group teaching times.  If a caregiver 
missed the teaching time for a particular club session they were likely to be exposed to the key 
messages from that lesson in subsequent group sessions and individual counseling sessions.    
The increases in Vitamin A coverage and receipt of household food rations suggest that the 
intervention increased access to other services.  It was not possible to assess what contribution 
access to these inputs made to growth effect but we think it was small.  Previous studies of 
household food rations suggest they do not make a direct impact on child growth.  Consistent 
use of chlorine water treatment can decrease exposure to pathogens and diarrhea risk, that in 
turn may impact growth. However the GHESKIO product was not distributed with extensive 
counseling.   Vitamin A supplementation protects children from morbidity but is not associated 
with growth outcomes in non-deficient children.   
Intermediates along causal pathway.  The intervention was designed to impact growth 
outcomes through two causal pathways based on known determinants of child growth [21]– 
increased nutrient intakes through supplement use and IYCF education and decreased nutrient 
losses related to diarrheal illness through education about hygiene and diarrhea treatment.   
Immediate outputs reflected caregiver knowledge that was gained or reinforced during the 
caregiver club and individual counseling visits. The changes in knowledge from baseline to the 
end of intervention about responsive feeding practices, diarrhea treatment and hygiene were 
statistically significant. This suggests that implementation of the intervention did follow 
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proposed pathway.  Mothers did receive and understand the messages being delivered.   
However with the exception of ORS use and feeding after diarrhea, at the end of intervention  
50% or less of participants identified any particular behavior which suggests that there is room 
for improvement in delivery of IYCF education.  
Intermediate outcomes were actual caregiver practices that would contribute to increased 
nutrient intakes or decreased nutrient losses.  Caregiver education included messages about 
improving dietary diversity [15, 22, 23] and frequency of feeding [12, 15] to increase nutrient 
intakes.  There was a slight decrease in the percentage of caregivers reporting feeding more 
food during diarrhea from 0 to 24 weeks and a slightly higher percentage of caregivers reported 
feeding less food at 24 weeks.  The small numbers of children with diarrhea at any given time 
limit interpretation of these findings.  Re-feeding after illness, an important behavior for growth 
[15] was not measured beyond the knowledge level.   
The intervention pathway assumes that child intake of the supplement will increase overall 
nutrient intake. It is likely that there is some displacement of other foods in the diet because of 
supplement use but overall dietary intake data were not available to confirm this.  It was also 
not possible to directly measure nutrient losses related to diarrhea.  The frequency of diarrheal 
episodes over time is associated with risk of stunting [24]. Diarrhea rates in the intervention 
group are comparable to national data from the 2006-5 DHS that showed 40.9% prevalence of 
diarrhea in the previous two weeks in the 6-11 month old age group [25].  Prevalence of 
diarrhea in the intervention group decreased across the intervention period, but without a 
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concurrent comparison group it is not possible to attribute this reduction to participation in the 
intervention.    
Overall, the findings related to comparability of groups at baseline, utilization of the 
intervention and analysis of the intervention pathway do support that the observed growth 
impact is attributable to participation in the IFSS. 
It is difficult to compare the relative impact of IYCF interventions with different strategies, types 
of supplementary foods, timing and delivery contexts. Dewey and Adu-Afarwuah [9] reviewed 2 
efficacy trials and 6 program evaluations of IYCF interventions that provided infants age 6-24 
months a supplementary food  along with another strategy, usually education, for at least four 
months. Reductions in the prevalence of growth faltering ranged from +1.3 to -9.4 percentage 
points in underweight and +2.9 to -6.8 percentage points in stunting. In our trial, the 
differences between intervention and historical control in prevalence of underweight (-14.0 
percentage points) and stunting (-11.6 percentage points) were much larger.   
There is an emerging body of literature around interventions that use energy-dense LNS for 
supplementary or complementary feeding in children under 24 months of age. In rural Malawi, 
125 children fed 200 kcal (6-9 months) to 300 kcal (after 9 months) of  LNS per day without 
education targeted at the mother gained an average of 1110 ± 440 g in weight and 6.6 ±1.4 cm 
in length from 6 to 12 months of age [26].   In our trial, the intervention group gained an 
average of 1552 ± 588 g in weight and 7.5 ± 2.12 cm in length over the same age range.  Results 
from a cluster-randomized study in Honduras that provided a LNS ration of 247 kcal/day to 6-12 
month olds and 373 kcal/day to 13-30 months olds along with IYCF education and household 
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food vouchers for a total duration of 6-12 month showed no impact on growth outcomes 
compared to children who received education and food vouchers only. However supplement 
adherence was only 23-38% [27].   
Study limitations.   The lack of randomization to treatment or a concurrent control group 
increased the likelihood of confounding in the observed association between IFSS participation 
and growth outcomes.  The plausibility-analysis design allowed us to develop a reasonable case 
for attributing the observed effect to the intervention.   Aspects of the intervention design were 
highly contextualized to the high rates of replacement feeding at GHESKIO during the study 
period.  Since the supplement was intended to compensate for lack of breast milk intake, the 
65-gram dose was higher than other contexts that have used 47-55 grams of LNS in the 6-12 
month age group [26]. 
CONCLUSION 
The findings of our study demonstrate that implementation of a clinic-based infant feeding 
support strategy that combines a supplement and infant feeding education is associated with 
reduced risk of growth faltering in HIV-exposed uninfected children from 6-12 months of age.  
Further research is needed to refine the duration of intervention, supplement dosing and 
education strategy to reflect the shift in HIV and infant feeding policies towards continued 
breastfeeding through at least the first year of life [6].  Implementation of the IFSS is ongoing at 
the GHESKIO Centers and the model is being refined and adapted with the aim of scaling-up 
throughout the country.     
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CHAPTER 5 
CONCLUSIONS 
 
This dissertation attempts to answer the questions of why and how to intervene to improve 
growth outcomes of HIV-exposed children in urban Haiti.  It describes the design, 
implementation and evaluation of a new Infant Feeding Support Strategy (IFSS) at the GHESKIO 
Centers.  The problem of growth faltering in late infancy was identified in chapters 1 and 2.  The 
context for intervention design and implementation was described in chapter 3.  The evaluation 
of intervention outcomes was presented in chapter 4.  In chapter 5, I will present key findings 
and their implications as well as recommendations for future research. 
KEY FINDINGS AND IMPLICATIONS  
Growth of HIV-exposed uninfected children at GHESKIO 
 Analysis of cross-sectional and longitudinal growth outcomes among HIV-exposed uninfected 
children from 0-23 months of age showed that prevalence of stunting was extremely high (40%) 
at birth. Size at birth was predictive of WAZ and LAZ across the first two years of life.  Mean 
growth indicators of GHESKIO children improved across the first six months of life, the period 
during which the majority of children received no-cost infant formula.  By 6 months of age they 
reached the same mean WAZ and LAZ as children in the general Haitian population.  Growth 
faltering in WAZ and LAZ started in late infancy and for LAZ, continued to age two years.   
 149 
 
To our knowledge this is the first research describing the growth outcomes of HIV-exposed 
uninfected children in a less-developed country who received a clinical (e.g. not research) 
standard of care that included replacement feeding, maternal HAART and cotrimoxazole 
prophylaxis.  Previous studies have reported that HIV-exposed uninfected infants are at higher 
risk of LBW.  None, however, has reported both LAZ and WLZ near birth and considered the 
implications of proportional growth restriction on subsequent postnatal growth pattern.   
Observed growth patterns suggest two problematic periods during which GHESKIO children 
have higher potential to benefit from a new intervention.   High rates of early stunting and the 
association between birth weight and subsequent postnatal growth outcomes, suggest the 
need for a prenatal intervention. However so little is known about the etiology of poor growth 
in utero in this population that we have little evidence to support a particular intervention 
approach.  After age 6 months is the other intervention period suggested by our findings.  The 
relatively small overall decline in mean LAZ in the GHESKIO children across the 6-12 month 
period suggests there was less potential to benefit than we had originally anticipated.   
Context and intervention design   
A number of contextual factors shaped the way we went about designing the IFSS so that it 
would be integrated into the local service-delivery context. The facilitating factors were 
predominantly related to having the support and mandate of higher-level stakeholders 
including PEFPAR and GHESKIO leadership.  The barriers were fundamentally related to the 
realities of working in a politically and socially chaotic environment with high rates of poverty.   
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Five “lessons learned” from the GHESEKIO IFSS are applicable to the development of integrated 
PMTCT and MCHN interventions at the clinical service delivery level.  In particular, effective 
integration of nutrition care into existing PTMCT and child health services requires that both 
the nutrition strategy and the existing services be adapted to fit together and that they reflect 
the realities of the end beneficiaries.  The caregivers club approach provides a promising 
foundation for integration of services at GHESKIO. Moving forward, GHESKIO will continue to 
adapt the IFSS model to reflect lessons learned in the pilot phase, respond to ongoing changes 
in the delivery context and better integrate PMTCT and MCHN services.   
Impact of the IFSS on growth of GHESKIO children  
Our findings suggest that it is possible to design and implement an effective clinic-based 
intervention to reduce the risk of growth faltering among HIV-exposed uninfected children. 
Unique relative to other published IYCF intervention studies, it involved a non-breastfed urban 
population and combined clinical and community-based delivery models.   
Participation in the IFSS was associated with a significant reduction in the prevalence of 
underweight and stunting among IFSS participants compared to historical controls.  The decline 
in growth faltering was a much higher magnitude than that seen in other IYCF interventions 
using education and supplementation approaches.  The lack of impact on mean growth 
indicators suggests that it was children who started at the lower end of the weight and length 
for age distributions who benefited more from the intervention.   
High compliance with supplement use and attendance at the educational sessions as well as 
reported changes in IYCF knowledge and practices suggest that the intervention did proceed 
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according to the postulated intervention pathways. Due to the small sample size and non-
randomized design, it is not possible to attribute the relative growth effect to the primary 
(supplement) compared to secondary (education) pathways.  However, the program-theory 
based evaluation design allowed us to identify potential weaknesses in the IFSS strategy.  For 
example, the changes in IYCF knowledge were relatively small – suggesting that there is need 
for improvement in the design and delivery of the education aspect of the program.   
Lipid-based nutrient supplements  
The immediate problem driving the need for a new IFSS among HIV-exposed infants at GHESKIO 
was the increased risk of growth faltering in late infancy which we assumed was primarily 
caused by inadequate dietary intake.  Provision of an energy-dense lipid-based nutrient 
supplement (LNS) was a feasible way to close the postulated nutrient gap in the diets of non-
breastfed children.  The study contributes to a growing body of literature around the use of LNS 
as a supplementary food. However, it does not address the more fundamental question of 
whether similar results could be obtained with a less-expensive supplement option such as a 
fortified cereal. 
Implications for scale-up of similar interventions  
Given the reach of PEPFAR’s global programs and the explicit mandate from PEPFAR for 
implementation of integrated PTMCT and MCHN services at the service delivery level, the 
lessons learned from our experience have the potential to be used and applied by a wide range 
of policy makers, program planners and implementers in the near future.   Our findings raise 
important questions regarding equity of service delivery in contexts with high rates of 
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malnutrition and poor child health outcomes in the general population. In using the nationally 
representative DHS children as a comparison group, we provide evidence for the inequity that 
can result from targeting services to HIV-exposed children in a context with widespread 
malnutrition.   The magnitude of decline in LAZ from 7-24 months among HIV-exposed 
uninfected GHESKIO children was much less than that seen in the general Haitian population.  
Contrary to general assumption that HIV-affected children are at higher risk of poor health 
outcomes, the targeting of services to HIV-affected children only may be exacerbating an 
inequity rather than resolving one.   
Building on the discussion of context started above, the GHESKIO IFSS experience contributes to 
a growing body of literature in implementation science that examines the processes and 
contexts underlying intervention choice, design, delivery, adaptation and scale-up [1, 2].  Policy 
makers and program planners should be cautioned against taking the exact approach used in 
the IFSS pilot study and applying it to other sites. As discussed throughout the dissertation, 
interventions must be adapted to delivery contexts.   
RECOMENDATIONS FOR FUTURE RESEARCH  
Growth of HIV-exposed uninfected children  
There is an urgent need for research about in utero growth and development of HIV-exposed 
children in under-resourced contexts.  Our findings suggest that prenatal factors are associated 
with growth outcomes across the first two years of life.   At this stage, a longitudinal cohort 
study that follows HIV-infected women from early pregnancy through delivery and then follows 
their children through the first two years of life would help us better understand the 
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determinants of the high rates of in utero stunting and the early “catch-up” pattern observed in 
our population.  Maternal weight gain, fetal skeletal growth, growth hormones (i.e. IGF-1, IGF-
2), ARV drug activity, micronutrient status, and dietary intake are among the variables to collect 
during the prenatal period.  For the postnatal period, measures of cotrimoxizaole exposure and 
variables related to “environmental enteropathy” should be collected in addition to growth, 
morbidity, micronutrient status, and dietary intake.   Specific research questions that could be 
addressed through a longitudinal cohort include: 
 What are the determinants of in utero growth outcomes among HIV-exposed children? 
 What in utero exposures and outcomes are associated with growth pattern in the postnatal 
period? More specifically, what factors are associated with improving z-scores observed 
across the 0-6 month period?  
 What is the postnatal growth pattern under revised breastfeeding and ARV protocols?  
 What is the association between cotrimoxazole prophylaxis and growth in HIV-exposed 
uninfected children exposed to poor hygienic environments? 
Pathways of intervention impact:  assessment of immediate determinants of growth outcomes  
Dietary intake data collected through 24-hour recalls and stool pathogen analysis by PCR 
methods are available for the intervention group and a small comparison group of 9-month old  
controls.  Using these data we can conduct a follow-up analysis to look at the two proximal 
determinants of growth – dietary intake and infection.  Dietary intake data will address the 
question of whether supplement use actually increased overall nutrient intake.  Depending on 
sample size and variability in outcomes, we might be able test whether specific dietary intake 
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factors or enteric pathogen types or loads were associated with relative benefit among 
intervention participants.   
Adaptation, integration and scale-up of IYCF interventions in the context of HIV/AIDS 
Implementation science-related research questions are only recently being addressed in the 
field of public health [1].  The roll-out of the GHESKIO integrated PMTCT and MCHN strategy 
provides the opportunity to address a wide-range of relevant questions including: 
 How did the lessons learned from the IFSS experience actually get applied to the design and 
implementation of the expanded program at GHESKIO? 
 How has the implementation context at GHESKIO changed post the 12 January 2010 
earthquake and with the introduction of breastfeeding + ARV protocols? 
Smaller-scale formative research about alternate supplement options and the delivery of IYCF 
education are needed to adapt the overall strategy to the changing contexts around infant and 
young feeding within GHESKIO and in other HIV-affected populations globally.  Based on our 
findings, future evaluations of similar interventions should include measures of social support 
and caregiver capacity as well as address additional aspects of the intervention delivery process 
including cost-effectiveness, staff motivation, and time burden for staff and participants.    
GHESKIO is limited by the relatively small size of its PMTCT program – so duration of such a  
study may need to be extended and/or additional sites recruited. HIV-affected populations in 
sub-Saharan Africa where the overall proportion of the population affected is much higher may 
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be more suitable for studies that compare different integrated PMTCT and MCHN delivery 
approaches. 
CONCLUSION 
The dissertation research has contributed to the knowledge and experience gap around the translation 
of PMTCT and IYCF recommendations into feasible interventions that improve infant growth outcomes 
in the context of HIV.    
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APPENDIX 
ABOUT THE MANBA FOTIFYE SUPPLEMENT 
Medika Mamba (a Haitain Creole name that means peanut butter medicine) is a peanut-based 
energy-dense micronutrient fortified food produced locally in Haiti by Meds and Food for Kids 
(MFK), a nongovernmental organization (www.medsandfoodforkids.org). MFK established a 
factory to produce Medika Mamba in Cap Haitien (a major Haitian city on the north coast) for 
use in local programs to treat severe and acutely malnourished children.  
The formulation of Medika Mamba was patterned after the similar product called PlumpyNut, 
produced by Nutriset (Lyon, France). Dr. Patricia Wolff, associate professor of pediatrics at the 
Washington University School of Medicine and executive director of MFK, has developed 
Medika Mamba and the MFK nutritional rehabilitation program in close consultation with 
Nutriset and with Dr. Mark Manary, also of Washington University, who is implementing similar 
work in Malawi and Sierra Leone [1].  MFK is in the midst of a UNICEF certification process for 
producers of Ready-to-Use Therapeutic Foods (RUTF) UNICEF has been charged with setting 
global quality standards for RUTF products.  
Although Medika Mamba was designed for therapeutic feeding of acutely malnourished 
children, we propose using a reformulated version (referred to here as fortified manba (FM)) as 
a daily 65g ration (approximately 6 teaspoons) to prevent malnutrition.  Based on independent 
commercial nutrient analyses made in preparation for this proposal, FM provides per 100 g: 
531kcal, 36.6 g fat, 15.3 g protein. Thus 65 g of FM would provide 50% of calories (equivalent to 
breast milk intake) and 90% of protein needs for a 6-8 month baby. The micronutrient premix 
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for the FM will be formulated to provide approximately 1 RDA/AI of micronutrients for an infant 
6-11 months old.  Zinc fortificant levels are based on the IZINCG estimate for high-phytate 
cereal based diets (5mg) [2]. By providing high nutrient value in relatively small volume, 
supplement is in accordance with relatively small gastric capacity of infants [3].   
It also allows for ongoing consumption of traditional Haitian weaning foods (see table 1) as the 
FM can be added to these porridges or consumed separately as a snack to meet overall daily 
nutrient targets.  
 
Cost and availability:  Compared to other imported micronutrient-fortified infant foods 
available in Haiti, FM is the most economical when considering cost per kcal (see Table 1).There 
are a number of locally produced flours marketed for infant feeding (e.g. plantain flour, manioc 
flour) however none of these products are micronutrient fortified and all require extended 
cooking times.  Akamil, a flour composed of mixed grains and legumes, was developed in rural 
Haiti in the mid-1970s and the high-protein formula was targeted at malnourished children.  
However, Akamil is not  micronutrient fortified, requires one hour cooking time (which 
Table A.1: Sample infant diet incorporating FM supplement with traditional Haitian infants foods 
compared to the recommended nutrient intake levels 
   
Medika 
Manba 
(65 g) 
Wheat 
flour 
gruel    
(250 g) 
Bread 
Gruel 
(125 g) 
Total 
nutrients 
consumed 
Recommended 
Intakes (DRI)  
6-8 mo 9-11 mo 
Energy (kcal) 345 277 109 731.4 769 858 
Protein (g) 9.9 4.4 1.7 16.0 11 11 
VA (μg) 300 0 0 300 500 500 
Fe (mg)  10.0 1.1 0.8 11.9 11 
Zn (mg)  5.0 0.4 0.05 5.4 3 
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increases costs through fuel usage), and the high-protein formulation  is no longer considered 
medically necessary, particularly in the treatment or prevention of mild to moderate 
malnutrition. 
Table A.2:  Micronutrient-fortified infant foods currently available in Haiti  
 
 
 
 
 
NOTES:  
1
 Monthly cost per child is calculated as the cost to provide a daily ration of 345 kcals for 30 
days.  
2 
 Supermarket costs are the posted prices for products at the Caribbean Supermarket in Delmas, 
Haiti on 3 August 2007.  Exchange rate: 1 USD = 7 Haitian dollars = 35 Haitian Gourdes 
Food safety: Cornell University faculty member Dr. Dan Brown has been working with MFK to 
assure safe levels of aflatoxin in the product by applying low technology sorting procedures.  
These procedures have been shown to remove 99.6% of the aflatoxins present in freshly 
harvested raw peanuts, with an average of only 0.2 parts per billion remaining, and often below 
the limits of detection. MFK tests batches with a one-step lateral flow immunochromatographic 
assay to ensure the sorting methods are effective. Periodic samples are also sent to Dr.Brown's 
lab for backup quantitative analyses by immunoaffinity/fluorometry and HPLC methods. 
Risk of peanut allergy is assumed to be very low in the Haitian population compared to the 
United States or other industrialized contexts [4].  However, protocols are in place for 
 
 
FM 
(1000g) 
Nutribien 
Infant cereal 
Supermarket
2
  
(400 g) 
Infamil Lipil 
Powder 
GHESKIO 
(12.9 oz) 
Infamil Lipil 
Powder 
Supermarket
2 
(12.9 oz) 
Calories per unit (kcal) 5300 1770 1880 1880 
Cost per unit  (USD) 6.00 4.08 7.60 12.50 
Cost per 100 kcal  0.11 0.23 0.42 0.66 
Monthly cost per child
1
   11.39 23.80 43.47 68.31 
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counseling about allergy risk during the informed consent process and for ongoing supervision 
by clinical staff to ensure mothers are prepared to respond immediately in case of adverse 
reaction.   
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